{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:46:25Z","timestamp":1791009985759,"version":"4.1.0"},"reference-count":303,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00203-025-04596-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:47:22Z","timestamp":1765525642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lipid nanoparticle\u2013based mRNA platforms for mucosal HIV vaccines: formulation advances, immune mechanisms, and translational pathways"],"prefix":"10.1007","volume":"208","author":[{"given":"Narinderjit Singh","family":"Sawaran Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Saeed","family":"Gataa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luma Hussain","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbulakshmi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kavitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutabar","family":"Latipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazira","family":"Madatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doniyor","family":"Jumanazarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Smerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"3","key":"4596_CR1","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.matt.2021.12.022","volume":"5","author":"A Abramson","year":"2022","unstructured":"Abramson A, Kirtane AR, Shi Y, Zhong G, Collins JE, Tamang S, Ishida K, Hayward A, Wainer J, Rajesh NU, Lu X, Gao Y, Karandikar P, Tang C, Lopes A, Wahane A, Reker D, Frederiksen MR, Jensen B, Langer R, Traverso G (2022) Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections. Matter 5(3):975\u2013987. https:\/\/doi.org\/10.1016\/j.matt.2021.12.022","journal-title":"Matter"},{"issue":"5","key":"4596_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami S, D\u2019Agostino MR, Zhang A, Stacey HD, Marzok A, Kang A, Singh R, Bavananthasivam J, Ye G, Luo X, Wang F, Ang JC, Zganiacz A, Sankar U, Kazhdan N, Koenig JFE, Phelps A, Gameiro SF, Tang S, Jordana M, Wan Y, Mossman KL, Jeyanathan M, Gillgrass A, Medina MFC, Smaill F, Lichty BD, Miller MS, Xing Z (2022) Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185(5):896-915.e19. https:\/\/doi.org\/10.1016\/j.cell.2022.02.005","journal-title":"Cell"},{"issue":"1","key":"4596_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/2211738510666220304111848","volume":"10","author":"S Agrawal","year":"2022","unstructured":"Agrawal S, Garg A, Varshney V (2022) Recent updates on applications of lipid-based nanoparticles for site-specific drug delivery. Pharm Nanotechnol 10(1):24\u201341. https:\/\/doi.org\/10.2174\/2211738510666220304111848","journal-title":"Pharm Nanotechnol"},{"key":"4596_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2019.111965","volume":"296","author":"A Aguilera-Garrido","year":"2019","unstructured":"Aguilera-Garrido A, Molina-Bol\u00edvar JA, G\u00e1lvez-Ruiz MJ, Galisteo-Gonz\u00e1lez F (2019) Mucoadhesive properties of liquid lipid nanocapsules enhanced by hyaluronic acid. J Mol Liq 296:111965. https:\/\/doi.org\/10.1016\/j.molliq.2019.111965","journal-title":"J Mol Liq"},{"issue":"1","key":"4596_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1021\/acs.biomac.7b01297","volume":"19","author":"M Alameh","year":"2018","unstructured":"Alameh M, Lavertu M, Tran-Khanh N, Chang C-Y, Lesage F, Bail M, Darras V, Chevrier A, Buschmann MD (2018) siRNA delivery with chitosan: influence of chitosan molecular weight, degree of deacetylation, and amine to phosphate ratio on in vitro silencing efficiency, hemocompatibility, biodistribution, and in vivo efficacy. Biomacromol 19(1):112\u2013131. https:\/\/doi.org\/10.1021\/acs.biomac.7b01297","journal-title":"Biomacromol"},{"issue":"2","key":"4596_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020236","volume":"11","author":"K Albakri","year":"2023","unstructured":"Albakri K, Khaity A, Atwan H, Saleh O, Al-Hajali M, Cadri S, Diab RA, Albazee E, Negida A (2023) Bell\u2019s palsy and COVID-19 vaccines: a systematic review and meta-analysis. Vaccines 11(2):236. https:\/\/doi.org\/10.3390\/vaccines11020236","journal-title":"Vaccines"},{"key":"4596_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1208\/s12249-020-01837-3","volume":"21","author":"MA Albarki","year":"2020","unstructured":"Albarki MA, Donovan MD (2020) Bigger or smaller? Size and loading effects on nanoparticle uptake efficiency in the nasal mucosa. AAPS PharmSciTech 21:294. https:\/\/doi.org\/10.1208\/s12249-020-01837-3","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"4596_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020206","volume":"13","author":"BN Aldosari","year":"2021","unstructured":"Aldosari BN, Alfagih IM, Almurshedi AS (2021) Lipid nanoparticles as delivery systems for RNA-based vaccines. Pharmaceutics 13(2):206. https:\/\/doi.org\/10.3390\/pharmaceutics13020206","journal-title":"Pharmaceutics"},{"issue":"19","key":"4596_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910603","volume":"25","author":"T Alejo","year":"2024","unstructured":"Alejo T, Toro-C\u00f3rdova A, Fern\u00e1ndez L, Rivero A, Stoian AM, P\u00e9rez L, Navarro V, Mart\u00ednez-Oliv\u00e1n J, de Miguel D (2024) Comprehensive optimization of a freeze-drying process achieving enhanced long-term stability and in vivo performance of lyophilized mRNA-LNPs. Int J Mol Sci 25(19):10603. https:\/\/doi.org\/10.3390\/ijms251910603","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4596_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12040409","volume":"12","author":"A Altay Benetti","year":"2024","unstructured":"Altay Benetti A, Tan EYZ, Chang ZW, Bae KH, Thwin MT, Muthuramalingam RPK, Liao K-C, Wan Y, Ng LFP, Renia L, Liu J, Chen X, Yang YY, White KP, Pastorin G (2024) Design and characterization of a new formulation for the delivery of COVID-19-mRNA vaccine to the nasal mucosa. Vaccines 12(4):409. https:\/\/doi.org\/10.3390\/vaccines12040409","journal-title":"Vaccines"},{"issue":"2","key":"4596_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020212","volume":"8","author":"G Anderluzzi","year":"2020","unstructured":"Anderluzzi G, Lou G, Gallorini S, Brazzoli M, Johnson R, O\u2019Hagan DT, Baudner BC, Perrie Y (2020) Investigating the impact of delivery system design on the efficacy of self-amplifying RNA vaccines. Vaccines 8(2):212. https:\/\/doi.org\/10.3390\/vaccines8020212","journal-title":"Vaccines"},{"key":"4596_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jconrel.2021.12.008","volume":"342","author":"G Anderluzzi","year":"2022","unstructured":"Anderluzzi G, Lou G, Woods S, Schmidt ST, Gallorini S, Brazzoli M, Johnson R, Roberts CW, O\u2019Hagan DT, Baudner BC, Perrie Y (2022) The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. J Control Release 342:388\u2013399. https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.008","journal-title":"J Control Release"},{"key":"4596_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpta.2022.100228","volume":"4","author":"ME Aranda-Barradas","year":"2022","unstructured":"Aranda-Barradas ME, Trejo-L\u00f3pez SE, Real AD, \u00c1lvarez-Almaz\u00e1n S, M\u00e9ndez-Albores A, Garc\u00eda-Tovar CG, Gonz\u00e1lez-D\u00edaz FR, Miranda-Castro SP (2022) Effect of molecular weight of chitosan on the physicochemical, morphological, and biological properties of polyplex nanoparticles intended for gene delivery. Carbohydrate Poly Technol Appl 4:100228. https:\/\/doi.org\/10.1016\/j.carpta.2022.100228","journal-title":"Carbohydrate Poly Technol Appl"},{"issue":"2","key":"4596_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.xphs.2024.12.013","volume":"114","author":"KS Arte","year":"2025","unstructured":"Arte KS, Chen M, Patil CD, Huang Y, Qu L, Zhou Q (2025) Recent advances in drying and development of solid formulations for stable mRNA and siRNA lipid nanoparticles. J Pharm Sci 114(2):805\u2013815. https:\/\/doi.org\/10.1016\/j.xphs.2024.12.013","journal-title":"J Pharm Sci"},{"issue":"6","key":"4596_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41591-020-0858-8","volume":"26","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam PS, Charles TP, Joag V, Bollimpelli VS, Scott MKD, Wimmers F, Burton SL, Labranche CC, Petitdemange C, Gangadhara S, Styles TM, Quarnstrom CF, Walter KA, Ketas TJ, Legere T, Jagadeesh Reddy PB, Kasturi SP, Tsai A, Yeung BZ, Gupta S, Tomai M, Vasilakos J, Shaw GM, Kang C-Y, Moore JP, Subramaniam S, Khatri P, Montefiori D, Kozlowski PA, Derdeyn CA, Hunter E, Masopust D, Amara RR, Pulendran B (2020) T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. Nat Med 26(6):932\u2013940. https:\/\/doi.org\/10.1038\/s41591-020-0858-8","journal-title":"Nat Med"},{"key":"4596_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ebiom.2016.11.024","volume":"14","author":"RD Astronomo","year":"2016","unstructured":"Astronomo RD, Santra S, Ballweber-Fleming L, Westerberg KG, Mach L, Hensley-McBain T et al (2016) Neutralization takes precedence over IgG or IgA isotype-related functions in mucosal HIV-1 antibody-mediated protection. EBioMedicine 14:97\u2013111. https:\/\/doi.org\/10.1016\/j.ebiom.2016.11.024","journal-title":"EBioMedicine"},{"issue":"6","key":"4596_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ymthe.2017.03.035","volume":"25","author":"K Bahl","year":"2017","unstructured":"Bahl K, Senn JJ, Yuzhakov O, Bulychev A, Brito LA, Hassett KJ, Laska ME, Smith M, Almarsson \u00d6, Thompson J, Ribeiro A (Mick), Watson M, Zaks T, Ciaramella G (2017) Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol Ther 25(6):1316\u20131327. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.035","journal-title":"Mol Ther"},{"key":"4596_CR18","doi-asserted-by":"publisher","first-page":"1091797","DOI":"10.3389\/fimmu.2022.1091797","volume":"13","author":"Y Bai","year":"2023","unstructured":"Bai Y, Liu D, He Q, Liu J, Mao Q, Liang Z (2023) Research progress on circular RNA vaccines. Front Immunol 13:1091797. https:\/\/doi.org\/10.3389\/fimmu.2022.1091797","journal-title":"Front Immunol"},{"issue":"6","key":"4596_CR19","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1021\/acs.molpharmaceut.0c01256","volume":"18","author":"MA Bakkari","year":"2021","unstructured":"Bakkari MA, Valiveti CK, Kaushik RS, Tummala H (2021) Toll-like receptor-4 (TLR4) agonist-based intranasal nanovaccine delivery system for inducing systemic and mucosal immunity. Mol Pharm 18(6):2233\u20132241. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c01256","journal-title":"Mol Pharm"},{"issue":"1","key":"4596_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/phe\/phv026","volume":"9","author":"B Bambery","year":"2016","unstructured":"Bambery B, Selgelid M, Weijer C, Savulescu J, Pollard AJ (2016) Ethical criteria for human challenge studies in infectious diseases: table 1. Public Health Ethics 9(1):92\u2013103. https:\/\/doi.org\/10.1093\/phe\/phv026","journal-title":"Public Health Ethics"},{"key":"4596_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.vetmic.2018.06.015","volume":"222","author":"H Bannai","year":"2018","unstructured":"Bannai H, Nemoto M, Tsujimura K, Yamanaka T, Kokado H, Kondo T, Matsumura T (2018) Comparison of protective efficacies between intranasal and intramuscular vaccination of horses with a modified live equine herpesvirus type-1 vaccine. Vet Microbiol 222:18\u201324. https:\/\/doi.org\/10.1016\/j.vetmic.2018.06.015","journal-title":"Vet Microbiol"},{"key":"4596_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jconrel.2024.07.078","volume":"374","author":"NV Bathula","year":"2024","unstructured":"Bathula NV, Friesen JJ, Casmil IC, Wayne CJ, Liao S, Soriano SKV, Ho CH, Strumpel A, Blakney AK (2024) Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity. J Controlled Release 374:28\u201338. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.078","journal-title":"J Controlled Release"},{"issue":"5","key":"4596_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/COH.0000000000000645","volume":"15","author":"AM Bauer","year":"2020","unstructured":"Bauer AM, Bar KJ (2020) Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure. Curr Opin HIV AIDS 15(5):275\u2013281. https:\/\/doi.org\/10.1097\/COH.0000000000000645","journal-title":"Curr Opin HIV AIDS"},{"key":"4596_CR24","doi-asserted-by":"publisher","first-page":"e0284339","DOI":"10.1371\/journal.pone.0284339","volume":"18","author":"JA Bauermeister","year":"2023","unstructured":"Bauermeister JA, Dominguez Islas C, Jiao Y, Tingler R, Brown E, Zemanek J et al (2023) A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035). PLOS One 18:e0284339. https:\/\/doi.org\/10.1371\/journal.pone.0284339","journal-title":"PLOS One"},{"key":"4596_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.omtn.2023.05.004","volume":"32","author":"M-C Bernard","year":"2023","unstructured":"Bernard M-C, Bazin E, Petiot N, Lemdani K, Commandeur S, Verdelet C, Margot S, Perkov V, Ripoll M, Garinot M, Ruiz S, Boudet F, Rokbi B, Haensler J (2023) The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system. Mol Ther Nucleic Acids 32:794\u2013806. https:\/\/doi.org\/10.1016\/j.omtn.2023.05.004","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"4596_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.therap.2022.07.009","volume":"78","author":"B Bertin","year":"2023","unstructured":"Bertin B, Grenet G, Pizzoglio-Billaudaz V, Lepelley M, Atzenhoffer M, Vial T (2023) Vaccines and Bell\u2019s palsy: a narrative review. Therapies 78(3):279\u2013292. https:\/\/doi.org\/10.1016\/j.therap.2022.07.009","journal-title":"Therapies"},{"key":"4596_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.17.594726","author":"E Bettini","year":"2024","unstructured":"Bettini E, Chudnovskiy A, Protti G, Nakadakari-Higa S, Ceglia S, Casta\u00f1o D et al (2024) Distinct components of nucleoside-modified messenger RNA vaccines cooperate to instruct efficient germinal center responses [Internet]. Immunology. https:\/\/doi.org\/10.1101\/2024.05.17.594726","journal-title":"Immunology"},{"issue":"12_Supplement","key":"4596_CR28","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2022-4215","volume":"82","author":"S Bhatnagar","year":"2022","unstructured":"Bhatnagar S, Revuri V, Shah M, Larson P, Ferguson D, Panyam J (2022) Abstract 4215: combination of STING and TLR 7\/8 agonists as vaccine adjuvants for cancer immunotherapy. Cancer Res 82(12_Supplement):4215. https:\/\/doi.org\/10.1158\/1538-7445.AM2022-4215","journal-title":"Cancer Res"},{"key":"4596_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","volume":"23","author":"D Bitounis","year":"2024","unstructured":"Bitounis D, Jacquinet E, Rogers MA, Amiji MM (2024) Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat Rev Drug Discov 23:281\u2013300. https:\/\/doi.org\/10.1038\/s41573-023-00859-3","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4596_CR30","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acsnano.0c00326","volume":"14","author":"AK Blakney","year":"2020","unstructured":"Blakney AK, Zhu Y, McKay PF, Bouton CR, Yeow J, Tang J, Hu K, Samnuan K, Grigsby CL, Shattock RJ, Stevens MM (2020) Big is beautiful: enhanced saRNA delivery and immunogenicity by a higher molecular weight, bioreducible, cationic polymer. ACS Nano 14(5):5711\u20135727. https:\/\/doi.org\/10.1021\/acsnano.0c00326","journal-title":"ACS Nano"},{"key":"4596_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jconrel.2021.08.029","volume":"338","author":"AK Blakney","year":"2021","unstructured":"Blakney AK, McKay PF, Hu K, Samnuan K, Jain N, Brown A, Thomas A, Rogers P, Polra K, Sallah H, Yeow J, Zhu Y, Stevens MM, Geall A, Shattock RJ (2021) Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines. J Controlled Release 338:201\u2013210. https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.029","journal-title":"J Controlled Release"},{"key":"4596_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","volume":"28","author":"K Bloom","year":"2021","unstructured":"Bloom K, Van Den Berg F, Arbuthnot P (2021) Self-amplifying RNA vaccines for infectious diseases. Gene Ther 28:117\u2013129. https:\/\/doi.org\/10.1038\/s41434-020-00204-y","journal-title":"Gene Ther"},{"key":"4596_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S1074-7613(00)80610-X","volume":"9","author":"M Bomsel","year":"1998","unstructured":"Bomsel M, Heyman M, Hocini H, Lagaye S, Belec L, Dupont C et al (1998) Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 9:277\u2013287. https:\/\/doi.org\/10.1016\/S1074-7613(00)80610-X","journal-title":"Immunity"},{"key":"4596_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1504432","volume":"15","author":"JS Booth","year":"2024","unstructured":"Booth JS, Wahid R, Bruder D, Salerno-Goncalves R (2024) Editorial: the synthesis of secretory immunoglobulin A in mucosal tissue: mucosal-associated invariant T, T follicular helper, and B cells. Front Immunol 15:1504432. https:\/\/doi.org\/10.3389\/fimmu.2024.1504432","journal-title":"Front Immunol"},{"issue":"1-2","key":"4596_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpharm.2005.04.037","volume":"299","author":"O Borges","year":"2005","unstructured":"Borges O, Borchard G, Verhoef JC, De Sousa A, Junginger HE (2005) Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm 299(1\u20132):155\u2013166. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.04.037","journal-title":"Int J Pharm"},{"issue":"8","key":"4596_CR36","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1007\/s13346-024-01635-5","volume":"14","author":"ML Borrajo","year":"2024","unstructured":"Borrajo ML, Lou G, Anthiya S, Lapuhs P, \u00c1lvarez DM, Tob\u00edo A, Loza MI, Vidal A, Alonso MJ (2024) Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines. Drug Deliv Transl Res 14(8):2046\u20132061. https:\/\/doi.org\/10.1007\/s13346-024-01635-5","journal-title":"Drug Deliv Transl Res"},{"key":"4596_CR37","doi-asserted-by":"publisher","unstructured":"Bouderhem R. Challenges Faced by States and the WHO in Efficiently Regulating the Use of mRNA Vaccines. IECV 2023 [Internet]. MDPI; 2023 [cited 2025 Sept 3]. p. 1. https:\/\/doi.org\/10.3390\/IECV2023-16530","DOI":"10.3390\/IECV2023-16530"},{"key":"4596_CR38","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3389\/fimmu.2019.01134","volume":"10","author":"A Bouteau","year":"2019","unstructured":"Bouteau A, Kervevan J, Su Q, Zurawski SM, Contreras V, Dereuddre-Bosquet N et al (2019) DC subsets regulate humoral immune responses by supporting the differentiation of distinct Tfh cells. Front Immunol 10:1134. https:\/\/doi.org\/10.3389\/fimmu.2019.01134","journal-title":"Front Immunol"},{"key":"4596_CR39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jconrel.2014.06.027","volume":"190","author":"LA Brito","year":"2014","unstructured":"Brito LA, O\u2019Hagan DT (2014) Designing and building the next generation of improved vaccine adjuvants. J Control Release 190:563\u2013579. https:\/\/doi.org\/10.1016\/j.jconrel.2014.06.027","journal-title":"J Control Release"},{"issue":"12","key":"4596_CR40","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1038\/mt.2014.133","volume":"22","author":"LA Brito","year":"2014","unstructured":"Brito LA, Chan M, Shaw CA, Hekele A, Carsillo T, Schaefer M, Archer J, Seubert A, Otten GR, Beard CW, Dey AK, Lilja A, Valiante NM, Mason PW, Mandl CW, Barnett SW, Dormitzer PR, Ulmer JB, Singh M, O\u2019Hagan DT, Geall AJ (2014) A cationic nanoemulsion for the delivery of next-generation RNA vaccines. Mol Ther 22(12):2118\u20132129. https:\/\/doi.org\/10.1038\/mt.2014.133","journal-title":"Mol Ther"},{"issue":"1","key":"4596_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010379","volume":"26","author":"T Bu","year":"2025","unstructured":"Bu T, Yang Z, Zhao J, Gao Y, Li F, Yang R (2025) Expanding the potential of circular RNA (CircRNA) vaccines: a promising therapeutic approach. Int J Mol Sci 26(1):379. https:\/\/doi.org\/10.3390\/ijms26010379","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4596_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/jimmun\/vkae067","volume":"214","author":"L Burmas","year":"2025","unstructured":"Burmas L, Lee WS, Kelly A, Webster R, Esterbauer R, Kent SJ, Wheatley AK, Juno JA, Tan H-X (2025) Modulation of germinal center and antibody dynamics via ipsilateral versus contralateral immunization against SARS-CoV-2. J Immunol 214(3):335\u2013346. https:\/\/doi.org\/10.1093\/jimmun\/vkae067","journal-title":"J Immunol"},{"issue":"2","key":"4596_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1515\/mr-2023-0008","volume":"3","author":"W Cao","year":"2023","unstructured":"Cao W, Xia T (2023) mRNA lipid nanoparticles induce immune tolerance to treat human diseases. Med Rev 3(2):180\u2013183. https:\/\/doi.org\/10.1515\/mr-2023-0008","journal-title":"Med Rev"},{"key":"4596_CR44","doi-asserted-by":"publisher","unstructured":"De Casteele IV, Plovyt M, Stuchl\u00edkov\u00e1 M, Lanssens M, Verschueren B, Denon Q, et al. Mucosal administration of lipid nanoparticles containing self-amplifying mRNA induces local uptake and expression in a pig model as a potential vaccination platform against STIs [Internet]. In Review; 2025 [cited 2025 Oct 21]. https:\/\/doi.org\/10.21203\/rs.3.rs-5682423\/v1","DOI":"10.21203\/rs.3.rs-5682423\/v1"},{"issue":"1","key":"4596_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11010020","volume":"11","author":"R Cazorla-Luna","year":"2019","unstructured":"Cazorla-Luna R, Notario-P\u00e9rez F, Mart\u00edn-Illana A, Ruiz-Caro R, Tamayo A, Rubio J, Veiga MD (2019) Chitosan-based mucoadhesive vaginal tablets for controlled release of the anti-HIV drug tenofovir. Pharmaceutics 11(1):20. https:\/\/doi.org\/10.3390\/pharmaceutics11010020","journal-title":"Pharmaceutics"},{"key":"4596_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744887","volume":"12","author":"RWY Chan","year":"2021","unstructured":"Chan RWY, Liu S, Cheung JY, Tsun JGS, Chan KC, Chan KYY, Fung GPG, Li AM, Lam HS (2021) The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines. Front Immunol 12:744887. https:\/\/doi.org\/10.3389\/fimmu.2021.744887","journal-title":"Front Immunol"},{"key":"4596_CR47","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","volume":"8","author":"N Chaudhary","year":"2024","unstructured":"Chaudhary N, Kasiewicz LN, Newby AN, Arral ML, Yerneni SS, Melamed JR et al (2024) Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d. Nat Biomed Eng 8:1483\u20131498. https:\/\/doi.org\/10.1038\/s41551-024-01256-w","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"4596_CR48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.6339\/JDS.202007_18(3).0020","volume":"18","author":"J Chen","year":"2021","unstructured":"Chen J, Ting N (2021) Design considerations for vaccine trials with a special focus on COVID-19 vaccine development. J Data Sci 18(3):550\u2013580. https:\/\/doi.org\/10.6339\/JDS.202007_18(3).0020","journal-title":"J Data Sci"},{"key":"4596_CR49","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.actbio.2021.08.046","volume":"135","author":"H Cheng","year":"2021","unstructured":"Cheng H, Cui Z, Guo S, Zhang X, Huo Y, Mao S (2021) Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin. Acta Biomater 135:506\u2013519. https:\/\/doi.org\/10.1016\/j.actbio.2021.08.046","journal-title":"Acta Biomater"},{"key":"4596_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568778","volume":"16","author":"VM Cnossen","year":"2025","unstructured":"Cnossen VM, Moreira PCL, Engelhardt OG, Samolej J, Groeneveld GH, Jochems SP, Huisman W, Pedersen GK, W\u00f8rzner K, Recek L, Piccini G, Trombetta CM, Aspelund A, Hoag A, Reiter M, Wick C, Muster T, Kamerling IMC (2025) Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortium. Front Immunol 16:1568778. https:\/\/doi.org\/10.3389\/fimmu.2025.1568778","journal-title":"Front Immunol"},{"issue":"8","key":"4596_CR51","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4049\/jimmunol.2200454","volume":"209","author":"MK Collins","year":"2022","unstructured":"Collins MK, McCutcheon CR, Petroff MG (2022) Impact of estrogen and progesterone on immune cells and host\u2013pathogen interactions in the lower female reproductive tract. J Immunol 209(8):1437\u20131449. https:\/\/doi.org\/10.4049\/jimmunol.2200454","journal-title":"J Immunol"},{"key":"4596_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac7732","author":"L Corey","year":"2015","unstructured":"Corey L, Gilbert PB, Tomaras GD, Haynes BF, Pantaleo G, Fauci AS (2015) Immune correlates of vaccine protection against HIV-1 acquisition. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aac7732","journal-title":"Sci Transl Med"},{"key":"4596_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152038","volume":"11","author":"CA Cosgrove","year":"2016","unstructured":"Cosgrove CA, Lacey CJ, Cope AV, Bartolf A, Morris G, Yan C et al (2016) Comparative immunogenicity of HIV-1 gp140 vaccine delivered by parenteral, and mucosal routes in female volunteers; MUCOVAC2, a randomized two centre study. PLoS ONE 11:e0152038. https:\/\/doi.org\/10.1371\/journal.pone.0152038","journal-title":"PLoS ONE"},{"key":"4596_CR54","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.4049\/jimmunol.1800219","volume":"202","author":"N \u00c7uburu","year":"2019","unstructured":"\u00c7uburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE et al (2019) A prime-pull-amplify vaccination strategy to maximize induction of circulating and genital-resident intraepithelial CD8+ memory T cells. J Immunol 202:1250\u20131264. https:\/\/doi.org\/10.4049\/jimmunol.1800219","journal-title":"J Immunol"},{"issue":"14","key":"4596_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411703","volume":"24","author":"L Daddi","year":"2023","unstructured":"Daddi L, Dorsett Y, Geng T, Bokoliya S, Yuan H, Wang P, Xu W, Zhou Y (2023) Baseline gut microbiome signatures correlate with immunogenicity of SARS-CoV-2 mRNA vaccines. Int J Mol Sci 24(14):11703. https:\/\/doi.org\/10.3390\/ijms241411703","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4596_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/jamp.2020.29029.cd","volume":"33","author":"C Darquenne","year":"2020","unstructured":"Darquenne C (2020) Deposition mechanisms. J Aerosol Med Pulm Drug Deliv 33(4):181\u2013185. https:\/\/doi.org\/10.1089\/jamp.2020.29029.cd","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"6","key":"4596_CR57","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","volume":"29","author":"R De Alwis","year":"2021","unstructured":"De Alwis R, Gan ES, Chen S, Leong YS, Tan HC, Zhang SL, Yau C, Low JGH, Kalimuddin S, Matsuda D, Allen EC, Hartman P, Park K-J, Alayyoubi M, Bhaskaran H, Dukanovic A, Bao Y, Clemente B, Vega J, Roberts S, Gonzalez JA, Sablad M, Yelin R, Taylor W, Tachikawa K, Parker S, Karmali P, Davis J, Sullivan BM, Sullivan SM, Hughes SG, Chivukula P, Ooi EE (2021) A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice. Mol Ther 29(6):1970\u20131983. https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.001","journal-title":"Mol Ther"},{"issue":"11","key":"4596_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101253","volume":"4","author":"CE Deal","year":"2023","unstructured":"Deal CE, Richards AF, Yeung T, Maron MJ, Wang Z, Lai Y-T, Fritz BR, Himansu S, Narayanan E, Liu D, Koleva R, Licht S, Hsiao CJ, Rajlic IL, Koch H, Kleyman M, Pulse ME, Weiss WJ, Doering JE, Lindberg SK, Mantis NJ, Carfi A, Plante OJ (2023) An mRNA-based platform for the delivery of pathogen-specific IgA into mucosal secretions. Cell Rep Med 4(11):101253. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101253","journal-title":"Cell Rep Med"},{"issue":"1","key":"4596_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-019-0712-5","volume":"50","author":"S Dhakal","year":"2019","unstructured":"Dhakal S, Renukaradhya GJ (2019) Nanoparticle-based vaccine development and evaluation against viral infections in pigs. Vet Res 50(1):90. https:\/\/doi.org\/10.1186\/s13567-019-0712-5","journal-title":"Vet Res"},{"key":"4596_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040385","volume":"7","author":"MDJ Dicks","year":"2012","unstructured":"Dicks MDJ, Spencer AJ, Edwards NJ, Wadell G, Bojang K, Gilbert SC et al (2012) A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity. PLoS ONE 7:e40385. https:\/\/doi.org\/10.1371\/journal.pone.0040385","journal-title":"PLoS ONE"},{"issue":"8","key":"4596_CR61","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.apsb.2019.10.002","volume":"10","author":"W Dong","year":"2020","unstructured":"Dong W, Ye J, Zhou J, Wang W, Wang H, Zheng X, Yang Y, Xia X, Liu Y (2020) Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein. Acta Pharm Sin B 10(8):1576\u20131585. https:\/\/doi.org\/10.1016\/j.apsb.2019.10.002","journal-title":"Acta Pharm Sin B"},{"issue":"9","key":"4596_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108192","volume":"34","author":"L Dong","year":"2023","unstructured":"Dong L, Ding J, Zhu L, Liu Y, Gao X, Zhou W (2023) Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy. Chin Chem Lett 34(9):108192. https:\/\/doi.org\/10.1016\/j.cclet.2023.108192","journal-title":"Chin Chem Lett"},{"issue":"22","key":"4596_CR63","doi-asserted-by":"publisher","first-page":"15085","DOI":"10.1021\/jacs.4c00451","volume":"146","author":"W Dong","year":"2024","unstructured":"Dong W, Li Z, Hou T, Shen Y, Guo Z, Su Y-T, Chen Z, Pan H, Jiang W, Wang Y (2024a) Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery. J Am Chem Soc 146(22):15085\u201315095. https:\/\/doi.org\/10.1021\/jacs.4c00451","journal-title":"J Am Chem Soc"},{"key":"4596_CR64","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1038\/s41467-024-50087-5","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Zhu W, Wei L, Kim JK, Ma Y, Kang S-M et al (2024b) Enhancing cross-protection against influenza by heterologous sequential immunization with mRNA LNP and protein nanoparticle vaccines. Nat Commun 15:5800. https:\/\/doi.org\/10.1038\/s41467-024-50087-5","journal-title":"Nat Commun"},{"issue":"21","key":"4596_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308447","volume":"11","author":"NM Drzeniek","year":"2024","unstructured":"Drzeniek NM, Kahwaji N, Picht S, Dimitriou IM, Schlickeiser S, Moradian H, Geissler S, Schmueck\u2010Henneresse M, Gossen M, Volk H-D (2024) In vitro transcribed mRNA immunogenicity induces chemokine\u2010mediated lymphocyte recruitment and can be gradually tailored by uridine modification. Adv Sci 11(21):2308447. https:\/\/doi.org\/10.1002\/advs.202308447","journal-title":"Adv Sci"},{"key":"4596_CR66","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1039\/C7BM01096F","volume":"6","author":"X-J Du","year":"2018","unstructured":"Du X-J, Wang J-L, Iqbal S, Li H-J, Cao Z-T, Wang Y-C et al (2018) The effect of surface charge on oral absorption of polymeric nanoparticles. Biomater Sci 6:642\u2013650. https:\/\/doi.org\/10.1039\/C7BM01096F","journal-title":"Biomater Sci"},{"key":"4596_CR67","doi-asserted-by":"publisher","DOI":"10.25004\/IJPSDR.2022.140119","author":"KR Dudhat","year":"2022","unstructured":"Dudhat KR, Patel HV (2022) Influence of particle size and particle deposition of inhaled medication in lung disease: a comrehensive review. Int J Pharm Sci Drug Res. https:\/\/doi.org\/10.25004\/IJPSDR.2022.140119","journal-title":"Int J Pharm Sci Drug Res"},{"key":"4596_CR68","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3389\/fimmu.2017.01077","volume":"8","author":"M Ebrahimian","year":"2017","unstructured":"Ebrahimian M, Hashemi M, Maleki M, Hashemitabar G, Abnous K, Ramezani M et al (2017) Co-delivery of Dual toll-like receptor agonists and antigen in Poly(Lactic-Co-Glycolic) acid\/polyethylenimine cationic hybrid nanoparticles promote efficient in vivo immune responses. Front Immunol 8:1077. https:\/\/doi.org\/10.3389\/fimmu.2017.01077","journal-title":"Front Immunol"},{"key":"4596_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw4236","volume":"11","author":"PK Ehrenberg","year":"2019","unstructured":"Ehrenberg PK, Shangguan S, Issac B, Alter G, Geretz A, Izumi T et al (2019) A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials. Sci Transl Med 11:eaaw4236. https:\/\/doi.org\/10.1126\/scitranslmed.aaw4236","journal-title":"Sci Transl Med"},{"issue":"3","key":"4596_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/apb.2022.0020","volume":"27","author":"D Eisenman","year":"2022","unstructured":"Eisenman D, Swindle S (2022) FDA guidance on shedding and environmental impact in clinical trials involving gene therapy products. Appl Biosaf 27(3):191\u2013197. https:\/\/doi.org\/10.1089\/apb.2022.0020","journal-title":"Appl Biosaf"},{"key":"4596_CR71","doi-asserted-by":"publisher","unstructured":"Elezaby RS, Nasr M, El-Sherbiny IM. Mucosal vaccination through chitosan-based delivery systems. Chitosan Biomed Appl [Internet]. Elsevier; 2022 [cited 2025 Aug 29]. p. 245\u201371. https:\/\/doi.org\/10.1016\/B978-0-12-821058-1.00002-2","DOI":"10.1016\/B978-0-12-821058-1.00002-2"},{"key":"4596_CR72","doi-asserted-by":"publisher","first-page":"e00824","DOI":"10.1128\/mSphere.00824-19","volume":"4","author":"SR Elizaldi","year":"2019","unstructured":"Elizaldi SR, Verma A, Walter KA, Rolston M, Dinasarapu AR, Durbin-Johnson BP et al (2019) Rectal Microbiome Composition Correlates with Humoral Immunity to HIV-1 in Vaccinated Rhesus Macaques. mSphere 4:e00824-19. https:\/\/doi.org\/10.1128\/mSphere.00824-19","journal-title":"mSphere"},{"key":"4596_CR73","doi-asserted-by":"publisher","unstructured":"Ellebedy A, Turner J, O\u2019Halloran J, Kalaidina E, Kim W, Schmitz A, et al. SARS-CoV-2 mRNA vaccines induce a robust germinal centre reaction in humans [Internet]. In Review; 2021 [cited 2025 Aug 31]. https:\/\/doi.org\/10.21203\/rs.3.rs-310773\/v1","DOI":"10.21203\/rs.3.rs-310773\/v1"},{"key":"4596_CR74","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jconrel.2024.07.052","volume":"373","author":"Y Fan","year":"2024","unstructured":"Fan Y, Rigas D, Kim LJ, Chang F-P, Zang N, McKee K, Kemball CC, Yu Z, Winkler P, Su W-C, Jessen P, Hura GL, Chen T, Koenig SG, Nagapudi K, Leung D, Yen C-W (2024) Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings. J Control Release 373:727\u2013737. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.052","journal-title":"J Control Release"},{"issue":"10","key":"4596_CR75","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.4161\/hv.29594","volume":"10","author":"H Fausther-Bovendo","year":"2014","unstructured":"Fausther-Bovendo H, Kobinger GP (2014) Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what\u2019s important? Hum Vaccin Immunother 10(10):2875\u20132884. https:\/\/doi.org\/10.4161\/hv.29594","journal-title":"Hum Vaccin Immunother"},{"key":"4596_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127078","volume":"53","author":"P F\u00e9lix","year":"2025","unstructured":"F\u00e9lix P, Melo AA, Costa JP, Cola\u00e7o M, Pereira D, N\u00fa\u00f1ez J, de Almeida LP, Borges O (2025) Exploring TLR agonists as adjuvants for COVID-19 oral vaccines. Vaccine 53:127078. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127078","journal-title":"Vaccine"},{"key":"4596_CR77","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cyto.2017.08.009","volume":"99","author":"L Fischetti","year":"2017","unstructured":"Fischetti L, Zhong Z, Pinder CL, Tregoning JS, Shattock RJ (2017) The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38\/JNK signalling. Cytokine 99:287\u2013296. https:\/\/doi.org\/10.1016\/j.cyto.2017.08.009","journal-title":"Cytokine"},{"issue":"25","key":"4596_CR78","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1182\/bloodadvances.2017011411","volume":"1","author":"JR Francica","year":"2017","unstructured":"Francica JR, Zak DE, Linde C, Siena E, Johnson C, Juraska M, Yates NL, Gunn B, De Gregorio E, Flynn BJ, Valiante NM, Malyala P, Barnett SW, Sarkar P, Singh M, Jain S, Ackerman M, Alam M, Ferrari G, Salazar A, Tomaras GD, O\u2019Hagan DT, Aderem A, Alter G, Seder RA (2017) Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Adv 1(25):2329\u20132342. https:\/\/doi.org\/10.1182\/bloodadvances.2017011411","journal-title":"Blood Adv"},{"issue":"3","key":"4596_CR79","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.ymthe.2021.02.003","volume":"29","author":"R Furlan","year":"2021","unstructured":"Furlan R (2021) A tolerizing mRNA vaccine against autoimmunity? Mol Ther 29(3):896\u2013897. https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.003","journal-title":"Mol Ther"},{"issue":"8","key":"4596_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11081333","volume":"11","author":"SC Gaglio","year":"2023","unstructured":"Gaglio SC, Perduca M, Zipeto D, Bardi G (2023) Efficiency of chitosan nanocarriers in vaccinology for mucosal immunization. Vaccines 11(8):1333. https:\/\/doi.org\/10.3390\/vaccines11081333","journal-title":"Vaccines"},{"key":"4596_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184303","volume":"12","author":"PA Gallay","year":"2017","unstructured":"Gallay PA, Chatterji U, Kirchhoff A, Gandarilla A, Gunawardana M, Pyles RB et al (2017) Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice. PLoS One 12:e0184303. https:\/\/doi.org\/10.1371\/journal.pone.0184303","journal-title":"PLoS One"},{"issue":"4","key":"4596_CR82","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/COH.0000000000000738","volume":"17","author":"JG Garc\u00eda-Lerma","year":"2022","unstructured":"Garc\u00eda-Lerma JG, McNicholl JM, Heneine W (2022) The predictive value of macaque models of preexposure prophylaxis for HIV prevention. Curr Opin HIV AIDS 17(4):179\u2013185. https:\/\/doi.org\/10.1097\/COH.0000000000000738","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"4596_CR83","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2021.02.030","volume":"184","author":"MS Gebre","year":"2021","unstructured":"Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH (2021) Novel approaches for vaccine development. Cell 184(6):1589\u20131603. https:\/\/doi.org\/10.1016\/j.cell.2021.02.030","journal-title":"Cell"},{"key":"4596_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106850","volume":"107","author":"T Geng","year":"2025","unstructured":"Geng T, Ding L, Liu M, Zou X, Gu Z, Lin H, Sun L (2025) Preservation of extracellular vesicles for drug delivery: a comparative evaluation of storage buffers. J Drug Deliv Sci Technol 107:106850. https:\/\/doi.org\/10.1016\/j.jddst.2025.106850","journal-title":"J Drug Deliv Sci Technol"},{"key":"4596_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705592","volume":"12","author":"S Gong","year":"2021","unstructured":"Gong S, Lakhashe SK, Hariraju D, Scinto H, Lanzavecchia A, Cameroni E, Corti D, Ratcliffe SJ, Rogers KA, Xiao P, Fontenot J, Villinger F, Ruprecht RM (2021) Cooperation between systemic IgG1 and mucosal dimeric IgA2 monoclonal anti-HIV Env antibodies: passive immunization protects Indian rhesus macaques against mucosal SHIV challenges. Front Immunol 12:705592. https:\/\/doi.org\/10.3389\/fimmu.2021.705592","journal-title":"Front Immunol"},{"issue":"17-18","key":"4596_CR86","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1080\/17576180.2024.2376949","volume":"16","author":"J Goodman","year":"2024","unstructured":"Goodman J, Cowan KJ, Golob M, Nelson R, Baltrukonis D, Bloem K, Butsel BV, Champion L, Cook J, Dang M, Galeva D, Guerrieri D, Jordan G, Krantz C, Lai C-H, Roch T, de Soares Sonza AL, Stevenson L, Tosar LP, Venema F, Widmaier H, Timmerman P (2024) Re-thinking the current paradigm for clinical immunogenicity assessment: an update from the discussion in the European Bioanalysis Forum. Bioanalysis 16(17\u201318):905\u2013913. https:\/\/doi.org\/10.1080\/17576180.2024.2376949","journal-title":"Bioanalysis"},{"issue":"29","key":"4596_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400509","volume":"13","author":"A Gordon","year":"2024","unstructured":"Gordon A, Li B, Witten J, Nguyen H, Anderson DG (2024) Inhalable dry powders for lung mRNA delivery. Adv Healthc Mater 13(29):2400509. https:\/\/doi.org\/10.1002\/adhm.202400509","journal-title":"Adv Healthc Mater"},{"key":"4596_CR88","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/pharmaceutics13020240","volume":"13","author":"R Goswami","year":"2021","unstructured":"Goswami R, O\u2019Hagan DT, Adamo R, Baudner BC (2021) Conjugation of mannans to enhance the potency of liposome nanoparticles for the delivery of RNA vaccines. Pharmaceutics 13:240. https:\/\/doi.org\/10.3390\/pharmaceutics13020240","journal-title":"Pharmaceutics"},{"issue":"3","key":"4596_CR89","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1021\/acsnano.2c11147","volume":"17","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ma Y, Chen X, Li M, Ma X, Cheng G, Xue C, Zuo YY, Sun B (2023) Mucus penetration of surface-engineered nanoparticles in various pH microenvironments. ACS Nano 17(3):2813\u20132828. https:\/\/doi.org\/10.1021\/acsnano.2c11147","journal-title":"ACS Nano"},{"key":"4596_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102922","volume":"58","author":"A Gutjahr","year":"2020","unstructured":"Gutjahr A, Papagno L, Vernejoul F, Lioux T, Jospin F, Chanut B, Perouzel E, Rochereau N, Appay V, Verrier B, Paul S (2020) New chimeric TLR7\/NOD2 agonist is a potent adjuvant to induce mucosal immune responses. EBioMedicine 58:102922. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102922","journal-title":"EBioMedicine"},{"issue":"1","key":"4596_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00485-x","volume":"7","author":"SA Hameed","year":"2022","unstructured":"Hameed SA, Paul S, Dellosa GKY, Jaraquemada D, Bello MB (2022) Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies. Npj Vaccines 7(1):71. https:\/\/doi.org\/10.1038\/s41541-022-00485-x","journal-title":"Npj Vaccines"},{"key":"4596_CR92","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han X, Alameh M-G, Butowska K, Knox JJ, Lundgreen K, Ghattas M et al (2023) Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat Nanotechnol 18:1105\u20131114. https:\/\/doi.org\/10.1038\/s41565-023-01404-4","journal-title":"Nat Nanotechnol"},{"key":"4596_CR93","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/vaccines12091012","volume":"12","author":"R Han","year":"2024","unstructured":"Han R, Su L, Cheng L (2024) Advancing human vaccine development using humanized mouse models. Vaccines 12:1012. https:\/\/doi.org\/10.3390\/vaccines12091012","journal-title":"Vaccines"},{"key":"4596_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-019-0189-9","volume":"13","author":"L He","year":"2019","unstructured":"He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, He H, Tang S, Sun Y, Liu F, Ding X, Zhang Y, Hu S, Xia L (2019) Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng 13:58. https:\/\/doi.org\/10.1186\/s13036-019-0189-9","journal-title":"J Biol Eng"},{"key":"4596_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571248","volume":"11","author":"Q He","year":"2020","unstructured":"He Q, Jiang L, Cao K, Zhang L, Xie X, Zhang S et al (2020) A systemic prime-intrarectal pull strategy raises rectum-resident CD8+ T cells for effective protection in a murine model of LM-OVA infection. Front Immunol 11:571248. https:\/\/doi.org\/10.3389\/fimmu.2020.571248","journal-title":"Front Immunol"},{"key":"4596_CR96","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/vaccines10020187","volume":"10","author":"C Herrera","year":"2022","unstructured":"Herrera C, Veazey R, Lemke MM, Arnold K, Kim JH, Shattock RJ (2022) Ex vivo evaluation of mucosal responses to vaccination with ALVAC and AIDSVAX of non-human primates. Vaccines 10:187. https:\/\/doi.org\/10.3390\/vaccines10020187","journal-title":"Vaccines"},{"key":"4596_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.616309","volume":"12","author":"K Hirahara","year":"2021","unstructured":"Hirahara K, Kokubo K, Aoki A, Kiuchi M, Nakayama T (2021) The role of CD4+ resident memory T cells in local immunity in the mucosal tissue \u2013 protection versus pathology. Front Immunol 12:616309. https:\/\/doi.org\/10.3389\/fimmu.2021.616309","journal-title":"Front Immunol"},{"issue":"11","key":"4596_CR98","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00816-22","volume":"66","author":"K Ho","year":"2022","unstructured":"Ho K, Dominguez-Islas C, Szydlo D, Edick S, Macagna N, Riddler SA, Brand RM, Jacobson CE, Kramzer L, Kunjara Na Ayudhya RP, Piper J, Marzinke MA, Bauermeister J, Nuttall J, Hillier SL, Hendrix CW (2022) MTN-033: a phase 1 study comparing applicator versus \u201cas lubricant\u201d delivery of rectal dapivirine gel. Antimicrob Agents Chemother 66(11):e00816-22. https:\/\/doi.org\/10.1128\/aac.00816-22","journal-title":"Antimicrob Agents Chemother"},{"key":"4596_CR99","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc7804","volume":"13","author":"C Hotz","year":"2021","unstructured":"Hotz C, Wagenaar TR, Gieseke F, Bangari DS, Callahan M, Cao H et al (2021) Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models. Sci Transl Med 13:eabc7804. https:\/\/doi.org\/10.1126\/scitranslmed.abc7804","journal-title":"Sci Transl Med"},{"issue":"12","key":"4596_CR100","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6(12):1078\u20131094. https:\/\/doi.org\/10.1038\/s41578-021-00358-0","journal-title":"Nat Rev Mater"},{"key":"4596_CR101","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3389\/fphar.2019.01196","volume":"10","author":"S Hua","year":"2019","unstructured":"Hua S (2019) Physiological and pharmaceutical considerations for rectal drug formulations. Front Pharmacol 10:1196. https:\/\/doi.org\/10.3389\/fphar.2019.01196","journal-title":"Front Pharmacol"},{"issue":"2","key":"4596_CR102","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13412","volume":"86","author":"SM Hughes","year":"2021","unstructured":"Hughes SM, Pandey U, Johnston C, Marrazzo J, Hladik F, Micks E (2021) Impact of the menstrual cycle and ethinyl estradiol\/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators. Am J Reprod Immunol 86(2):e13412. https:\/\/doi.org\/10.1111\/aji.13412","journal-title":"Am J Reprod Immunol"},{"key":"4596_CR103","doi-asserted-by":"publisher","unstructured":"Hughes SM, Levy CN, Pandey U, Katz R, Lokken EM, Mugo NR, et al. Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data. figshare; 2020;2700999 Bytes. https:\/\/doi.org\/10.6084\/M9.FIGSHARE.12881333.V1","DOI":"10.6084\/M9.FIGSHARE.12881333.V1"},{"key":"4596_CR104","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1182\/blood-2012-04-422303","volume":"120","author":"EM Hur","year":"2012","unstructured":"Hur EM, Patel SN, Shimizu S, Rao DS, Gnanapragasam PNP, An DS et al (2012) Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 120:4571\u20134582. https:\/\/doi.org\/10.1182\/blood-2012-04-422303","journal-title":"Blood"},{"key":"4596_CR105","unstructured":"IAVI and Moderna launch first-in-Africa clinical trial of the mRNA-1644 HIV vaccine development program [Internet]. IAVI; 2023. https:\/\/www.iavi.org\/press-release\/iavi-and-moderna-launch-first-in-africa-clinical-trial-of-mrna-hiv-vaccine-development-program\/"},{"key":"4596_CR106","unstructured":"National Institutes of Health. NIH launches clinical trial of three mRNA HIV vaccines. 2022;"},{"issue":"1","key":"4596_CR107","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/jamp.2013.1093","volume":"28","author":"K Inthavong","year":"2015","unstructured":"Inthavong K, Fung MC, Yang W, Tu J (2015) Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure. J Aerosol Med Pulm Drug Deliv 28(1):59\u201367. https:\/\/doi.org\/10.1089\/jamp.2013.1093","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"5","key":"4596_CR108","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.ymthe.2022.02.023","volume":"30","author":"H Ishii","year":"2022","unstructured":"Ishii H, Terahara K, Nomura T, Okazaki M, Yamamoto H, Shu T, Sakawaki H, Miura T, Watkins DI, Matano T (2022) Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag\/Vif-specific CD8+ T cells but not CD4+ T cells. Mol Ther 30(5):2048\u20132057. https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.023","journal-title":"Mol Ther"},{"key":"4596_CR109","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf1198","volume":"6","author":"N Iwanaga","year":"2021","unstructured":"Iwanaga N, Chen K, Yang H, Lu S, Hoffmann JP, Wanek A et al (2021) Vaccine-driven lung TRM cells provide immunity against Klebsiella via fibroblast IL-17R signaling. Sci Immunol 6:eabf1198. https:\/\/doi.org\/10.1126\/sciimmunol.abf1198","journal-title":"Sci Immunol"},{"issue":"1","key":"4596_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0159-8","volume":"5","author":"NAC Jackson","year":"2020","unstructured":"Jackson NAC, Kester KE, Casimiro D, Gurunathan S, DeRosa F (2020) The promise of mRNA vaccines: a biotech and industrial perspective. NPJ Vaccines 5(1):11. https:\/\/doi.org\/10.1038\/s41541-020-0159-8","journal-title":"NPJ Vaccines"},{"issue":"4","key":"4596_CR111","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029132","volume":"10","author":"SC Jameson","year":"2018","unstructured":"Jameson SC, Masopust D (2018) What is the predictive value of animal models for vaccine efficacy in humans? Reevaluating the potential of mouse models for the human immune system. Cold Spring Harb Perspect Biol 10(4):a029132. https:\/\/doi.org\/10.1101\/cshperspect.a029132","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4596_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2024.101748","volume":"85","author":"E Jamrozik","year":"2024","unstructured":"Jamrozik E, Littler K, Meln I, Van Molle W, Morel S, Olesen OF, Rubbrecht M, Balasingam S, Neels P (2024) Ethical approval for controlled human infectious model clinical trial protocols \u2013 a workshop report. Biologicals 85:101748. https:\/\/doi.org\/10.1016\/j.biologicals.2024.101748","journal-title":"Biologicals"},{"issue":"11","key":"4596_CR113","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1080\/17425247.2022.2131767","volume":"19","author":"EM Jansen","year":"2022","unstructured":"Jansen EM, Frijlink HW, Hinrichs WL, Ruigrok MJ (2022) Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert Opin Drug Deliv 19(11):1471\u20131485. https:\/\/doi.org\/10.1080\/17425247.2022.2131767","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"4596_CR114","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.xphs.2022.01.032","volume":"111","author":"V Jawa","year":"2022","unstructured":"Jawa V, Maamary J, Swanson M, Zhang S, Montgomery D (2022) Implementing a clinical immunogenicity strategy using preclinical risk assessment outputs. J Pharm Sci 111(4):960\u2013969. https:\/\/doi.org\/10.1016\/j.xphs.2022.01.032","journal-title":"J Pharm Sci"},{"key":"4596_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1597417","volume":"16","author":"JH Jeon","year":"2025","unstructured":"Jeon JH, Kim S, Kim S-Y, Shin K-S, Park B, Chang S, Kang C-Y, Kim Y-J, Park J-E, Youk S, Kim D, Yeo J (2025) Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants. Front Immunol 16:1597417. https:\/\/doi.org\/10.3389\/fimmu.2025.1597417","journal-title":"Front Immunol"},{"issue":"1","key":"4596_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60726-0","volume":"16","author":"M Jeyanathan","year":"2025","unstructured":"Jeyanathan M, Afkhami S, D\u2019Agostino MR, Satia I, Fritz DK, Miyasaki K, Ang JC, Zganiacz A, Howie KJ, Swinton M, Aguirre E, Zheng MB, Kazhdan N, Dvorkin-Gheva A, Mbuagbaw L, Medina MFC, Diab N, Brister DL, Gauvreau GM, Lichty BD, Miller MS, Smaill F, Xing Z (2025) Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial. Nat Commun 16(1):6000. https:\/\/doi.org\/10.1038\/s41467-025-60726-0","journal-title":"Nat Commun"},{"key":"4596_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120391","volume":"598","author":"Z Jia","year":"2021","unstructured":"Jia Z, Guo Z, Yang C-T, Prestidge C, Thierry B (2021) \u201cMucus-on-Chip\u201d: a new tool to study the dynamic penetration of nanoparticulate drug carriers into mucus. Int J Pharm 598:120391. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120391","journal-title":"Int J Pharm"},{"issue":"2","key":"4596_CR118","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2217076","volume":"19","author":"Y Jia","year":"2023","unstructured":"Jia Y, Fu B, Dong L, Zhao M (2023) Sweet syndrome induced by SARS-CoV-2 vaccines: a systematic review of patient-report studies. Hum Vaccin Immunother 19(2):2217076. https:\/\/doi.org\/10.1080\/21645515.2023.2217076","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"4596_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103507","volume":"28","author":"X Jiang","year":"2023","unstructured":"Jiang X, Wang N, Liu C, Zhuo Y, Liang L, Gan Y, Yu M (2023) Oral delivery of nucleic acid therapeutics: challenges, strategies, and opportunities. Drug Discov Today 28(4):103507. https:\/\/doi.org\/10.1016\/j.drudis.2023.103507","journal-title":"Drug Discov Today"},{"key":"4596_CR120","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/vaccines13010014","volume":"13","author":"H Jo","year":"2024","unstructured":"Jo H, Jeoung J, Kim W, Jeoung D (2024) Regulating immune responses induced by PEGylated messenger RNA\u2013lipid nanoparticle vaccine. Vaccines 13:14. https:\/\/doi.org\/10.3390\/vaccines13010014","journal-title":"Vaccines"},{"key":"4596_CR121","doi-asserted-by":"publisher","DOI":"10.1101\/573394","author":"DI Jones","year":"2019","unstructured":"Jones DI, Pollara JJ, Johnson-Weaver BT, LaBranche CC, Montefiori DC, Pickup DJ et al (2019) Optimized mucosal MVA Prime\/ soluble gp120 boost vaccination regimen induces similar antibody responses as an intramuscular regimen [Internet]. Immunology. https:\/\/doi.org\/10.1101\/573394","journal-title":"Immunology"},{"key":"4596_CR122","doi-asserted-by":"publisher","unstructured":"Kaneko K, Osman N, Carini V, Scagnetti G, Saleem I. Overview of the Advantages and Disadvantages of Different Mucosal Sites for the Delivery of Nanoparticles. In: Muttil P, Kunda NK, editors. Mucosal Deliv Drugs Biol Nanoparticles [Internet]. Cham: Springer International Publishing; 2020 [cited 2025 Sept 3]. p. 61\u201382. https:\/\/doi.org\/10.1007\/978-3-030-35910-2_3","DOI":"10.1007\/978-3-030-35910-2_3"},{"issue":"12","key":"4596_CR123","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.it.2023.10.008","volume":"44","author":"JM Kastenschmidt","year":"2023","unstructured":"Kastenschmidt JM, Sureshchandra S, Wagar LE (2023) Leveraging human immune organoids for rational vaccine design. Trends Immunol 44(12):938\u2013944. https:\/\/doi.org\/10.1016\/j.it.2023.10.008","journal-title":"Trends Immunol"},{"key":"4596_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811924-2.00003-1","author":"BL Kelsall","year":"2020","unstructured":"Kelsall BL (2020) Mucosal antigen sampling across the villus epithelium by epithelial and myeloid cells. Mucosal Vaccines. https:\/\/doi.org\/10.1016\/B978-0-12-811924-2.00003-1","journal-title":"Mucosal Vaccines"},{"issue":"4","key":"4596_CR125","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1248\/bpb.b19-00743","volume":"43","author":"IA Khalil","year":"2020","unstructured":"Khalil IA, Younis MA, Kimura S, Harashima H (2020) Lipid nanoparticles for cell-specific in vivo targeted delivery of nucleic acids. Biol Pharm Bull 43(4):584\u2013595. https:\/\/doi.org\/10.1248\/bpb.b19-00743","journal-title":"Biol Pharm Bull"},{"key":"4596_CR126","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","volume":"16","author":"J Kim","year":"2022","unstructured":"Kim J, Jozic A, Lin Y, Eygeris Y, Bloom E, Tan X et al (2022) Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation. ACS Nano 16:14792\u201314806. https:\/\/doi.org\/10.1021\/acsnano.2c05647","journal-title":"ACS Nano"},{"issue":"12","key":"4596_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122781","volume":"15","author":"H Kim","year":"2023","unstructured":"Kim H, Ahn Y-R, Kim M, Choi J, Shin S, Kim H-O (2023) Charge-complementary polymersomes for enhanced mRNA delivery. Pharmaceutics 15(12):2781. https:\/\/doi.org\/10.3390\/pharmaceutics15122781","journal-title":"Pharmaceutics"},{"issue":"8","key":"4596_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080881","volume":"9","author":"RG King","year":"2021","unstructured":"King RG, Silva-Sanchez A, Peel JN, Botta D, Dickson AM, Pinto AK, Meza-Perez S, Allie SR, Schultz MD, Liu M, Bradley JE, Qiu S, Yang G, Zhou F, Zumaquero E, Simpler TS, Mousseau B, Killian JT Jr., Dean B, Shang Q, Tipper JL, Risley CA, Harrod KS, Feng T, Lee Y, Shiberu B, Krishnan V, Peguillet I, Zhang J, Green TJ, Randall TD, Suschak JJ, Georges B, Brien JD, Lund FE, Roberts MS (2021) Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 and fully protects mice from lethal challenge. Vaccines 9(8):881. https:\/\/doi.org\/10.3390\/vaccines9080881","journal-title":"Vaccines"},{"key":"4596_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102388","volume":"85","author":"AR Kirtane","year":"2023","unstructured":"Kirtane AR, Tang C, Freitas D, Bernstock JD, Traverso G (2023) Challenges and opportunities in the development of mucosal mRNA vaccines. Curr Opin Immunol 85:102388. https:\/\/doi.org\/10.1016\/j.coi.2023.102388","journal-title":"Curr Opin Immunol"},{"key":"4596_CR130","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/vaccines9020081","volume":"9","author":"I Knezevic","year":"2021","unstructured":"Knezevic I, Liu MA, Peden K, Zhou T, Kang H-N (2021) Development of mRNA vaccines: scientific and regulatory issues. Vaccines 9:81. https:\/\/doi.org\/10.3390\/vaccines9020081","journal-title":"Vaccines"},{"key":"4596_CR131","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1021\/acsnano.9b00326","volume":"13","author":"FC Knight","year":"2019","unstructured":"Knight FC, Gilchuk P, Kumar A, Becker KW, Sevimli S, Jacobson ME et al (2019) Mucosal immunization with a pH-responsive nanoparticle vaccine induces protective CD8+ lung-resident memory T cells. ACS Nano 13:10939\u201310960. https:\/\/doi.org\/10.1021\/acsnano.9b00326","journal-title":"ACS Nano"},{"key":"4596_CR132","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3389\/fimmu.2019.02345","volume":"10","author":"N Kobayashi","year":"2019","unstructured":"Kobayashi N, Takahashi D, Takano S, Kimura S, Hase K (2019) The roles of Peyer\u2019s patches and microfold cells in the gut immune system: relevance to autoimmune diseases. Front Immunol 10:2345. https:\/\/doi.org\/10.3389\/fimmu.2019.02345","journal-title":"Front Immunol"},{"key":"4596_CR133","doi-asserted-by":"publisher","unstructured":"Komori M, Morey AL, Qui\u00f1ones-Molina AA, Fofana J, Romero L, Peters E, et al. Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine [Internet]. Immunology; 2023 [cited 2025 Aug 27]. https:\/\/doi.org\/10.1101\/2023.11.01.565056","DOI":"10.1101\/2023.11.01.565056"},{"key":"4596_CR134","doi-asserted-by":"publisher","first-page":"24224","DOI":"10.1038\/s41598-025-06880-3","volume":"15","author":"R Koolaparambil Mukesh","year":"2025","unstructured":"Koolaparambil Mukesh R, Hill T, Kaiser F, Prado-Smith J, Schulz JE, Gallogly S et al (2025) Intranasal booster induces durable mucosal immunity against SARS-CoV-2 in mice. Sci Rep 15:24224. https:\/\/doi.org\/10.1038\/s41598-025-06880-3","journal-title":"Sci Rep"},{"key":"4596_CR135","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam9169","volume":"2","author":"JK Krishnaswamy","year":"2017","unstructured":"Krishnaswamy JK, Gowthaman U, Zhang B, Mattsson J, Szeponik L, Liu D et al (2017) Migratory CD11b+ conventional dendritic cells induce T follicular helper cell\u2013dependent antibody responses. Sci Immunol 2:eaam9169. https:\/\/doi.org\/10.1126\/sciimmunol.aam9169","journal-title":"Sci Immunol"},{"key":"4596_CR136","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2017.01581","volume":"8","author":"V Kulkarni","year":"2017","unstructured":"Kulkarni V, Ruprecht RM (2017) Mucosal IgA responses: damaged in established HIV infection\u2014yet, effective weapon against HIV transmission. Front Immunol 8:1581. https:\/\/doi.org\/10.3389\/fimmu.2017.01581","journal-title":"Front Immunol"},{"key":"4596_CR137","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2025.2523991","author":"A Kumar","year":"2025","unstructured":"Kumar A, Avlani D, Murthy SN, Shivakumar HN, Jindal S (2025) Emerging trends in polymeric mucoadhesive nanocarriers: a promising option for intravaginal HIV preexposure prophylaxis. J Drug Target. https:\/\/doi.org\/10.1080\/1061186X.2025.2523991","journal-title":"J Drug Target"},{"key":"4596_CR138","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add3075","volume":"7","author":"M K\u00fcnzli","year":"2022","unstructured":"K\u00fcnzli M, O\u2019Flanagan SD, LaRue M, Talukder P, Dileepan T, Stolley JM et al (2022) Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci Immunol 7:eadd3075. https:\/\/doi.org\/10.1126\/sciimmunol.add3075","journal-title":"Sci Immunol"},{"key":"4596_CR139","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn5311","volume":"7","author":"M Kuraoka","year":"2022","unstructured":"Kuraoka M, Yeh C-H, Bajic G, Kotaki R, Song S, Windsor I et al (2022) Recall of B cell memory depends on relative locations of prime and boost immunization. Sci Immunol 7:eabn5311. https:\/\/doi.org\/10.1126\/sciimmunol.abn5311","journal-title":"Sci Immunol"},{"key":"4596_CR140","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41590-025-02156-0","volume":"26","author":"D Kwon","year":"2025","unstructured":"Kwon D, Mao T, Israelow B, Santos Guedes De S\u00e1 K, Dong H, Iwasaki A (2025) Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice. Nat Immunol 26:908\u2013919. https:\/\/doi.org\/10.1038\/s41590-025-02156-0","journal-title":"Nat Immunol"},{"issue":"12","key":"4596_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122174","volume":"10","author":"Y-H Lai","year":"2022","unstructured":"Lai Y-H, Chen H-Y, Chiu H-H, Kang Y-N, Wong S-B (2022) Peripheral nervous system adverse events after the administration of mRNA vaccines: a systematic review and meta-analysis of large-scale studies. Vaccines 10(12):2174. https:\/\/doi.org\/10.3390\/vaccines10122174","journal-title":"Vaccines"},{"key":"4596_CR142","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1039\/D2BM02031A","volume":"11","author":"A Lamoot","year":"2023","unstructured":"Lamoot A, Lammens J, De Lombaerde E, Zhong Z, Gontsarik M, Chen Y et al (2023) Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids. Biomater Sci 11:4327\u20134334. https:\/\/doi.org\/10.1039\/D2BM02031A","journal-title":"Biomater Sci"},{"key":"4596_CR143","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","volume":"12","author":"D Lapuente","year":"2021","unstructured":"Lapuente D, Fuchs J, Willar J, Vieira Ant\u00e3o A, Eberlein V, Uhlig N et al (2021) Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat Commun 12:6871. https:\/\/doi.org\/10.1038\/s41467-021-27063-4","journal-title":"Nat Commun"},{"key":"4596_CR144","doi-asserted-by":"publisher","first-page":"253.01","DOI":"10.4049\/jimmunol.210.Supp.253.01","volume":"210","author":"D Lapuente","year":"2023","unstructured":"Lapuente D, Viherlehto V, Fuchs J, Willar J, Antao AV, Eberlein V et al (2023) Adenoviral vector vaccines are effective mucosal booster modalities to elevate systemic and establish mucosal immunity against SARS-CoV-2. J Immunol 210:253.01-253.01. https:\/\/doi.org\/10.4049\/jimmunol.210.Supp.253.01","journal-title":"J Immunol"},{"key":"4596_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1456538","volume":"4","author":"BL Laube","year":"2024","unstructured":"Laube BL, Kesavan J, Farias G, Karavas N, Blondel M, Suman J (2024) Targeting aerosol delivery to regions of nasal-associated lymphoid tissue (NALT) in three dimensional models of human intranasal airways using the BiVax intranasal atomizer. Front Drug Deliv 4:1456538. https:\/\/doi.org\/10.3389\/fddev.2024.1456538","journal-title":"Front Drug Deliv"},{"key":"4596_CR146","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","volume":"53","author":"K Lederer","year":"2020","unstructured":"Lederer K, Casta\u00f1o D, G\u00f3mez Atria D, Oguin TH, Wang S, Manzoni TB et al (2020) SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity 53:1281-1295.e5. https:\/\/doi.org\/10.1016\/j.immuni.2020.11.009","journal-title":"Immunity"},{"key":"4596_CR147","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","volume":"55","author":"Y Lee","year":"2023","unstructured":"Lee Y, Jeong M, Park J, Jung H, Lee H (2023) Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. Exp Mol Med 55:2085\u20132096. https:\/\/doi.org\/10.1038\/s12276-023-01086-x","journal-title":"Exp Mol Med"},{"issue":"5","key":"4596_CR148","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/infdis\/jiad392","volume":"229","author":"Y-S Lee","year":"2024","unstructured":"Lee Y-S, Bang Y-J, Yoo S, Park S-I, Park H-J, Kwak HW, Bae S-H, Kim J-Y, Youn S-B, Roh G, Lee S, Kwon SP, Bang E-K, Keum G, Nam J-H, Hong S-H (2024) Analysis of the immunostimulatory effects of cytokine-expressing internal ribosome entry site\u2013based RNA adjuvants and their applications. J Infect Dis 229(5):1408\u20131418. https:\/\/doi.org\/10.1093\/infdis\/jiad392","journal-title":"J Infect Dis"},{"key":"4596_CR149","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6750-8-89","volume":"8","author":"X Li","year":"2008","unstructured":"Li X, Kong X, Shi S, Zheng X, Guo G, Wei Y et al (2008) Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol 8:89. https:\/\/doi.org\/10.1186\/1472-6750-8-89","journal-title":"BMC Biotechnol"},{"key":"4596_CR150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","volume":"228","author":"M Li","year":"2016","unstructured":"Li M, Zhao M, Fu Y, Li Y, Gong T, Zhang Z, Sun X (2016) Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. J Control Release 228:9\u201319. https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.043","journal-title":"J Control Release"},{"key":"4596_CR151","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41541-023-00732-9","volume":"8","author":"M Li","year":"2023","unstructured":"Li M, Jia L, Xie Y, Ma W, Yan Z, Liu F et al (2023a) Lyophilization process optimization and molecular dynamics simulation of mRNA-LNPs for SARS-CoV-2 vaccine. NPJ Vaccines 8:153. https:\/\/doi.org\/10.1038\/s41541-023-00732-9","journal-title":"NPJ Vaccines"},{"key":"4596_CR153","doi-asserted-by":"publisher","DOI":"10.53941\/rmd.2024.100003","author":"W Li","year":"2024","unstructured":"Li W, Wang T, Chen J, Guo M, Ling L, Higuchi A (2024) Application of saccharide cryoprotectants in the freezing or lyophilization process of lipid nanoparticles encapsulating gene drugs for regenerative medicine. Regen Med Dent. https:\/\/doi.org\/10.53941\/rmd.2024.100003","journal-title":"Regen Med Dent."},{"key":"4596_CR154","doi-asserted-by":"publisher","first-page":"2309770","DOI":"10.1002\/advs.202309770","volume":"11","author":"W Li","year":"2024","unstructured":"Li W, Li Y, Li J, Meng J, Jiang Z, Yang C et al (2024) All- Trans -retinoic acid-adjuvanted mRNA vaccine induces mucosal anti-tumor immune responses for treating colorectal cancer. Adv Sci 11:2309770. https:\/\/doi.org\/10.1002\/advs.202309770","journal-title":"Adv Sci"},{"key":"4596_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125335","volume":"672","author":"H-Y Li","year":"2025","unstructured":"Li H-Y, Paramanandana A, Kim SY, Granger L, Raimi-Abraham BT, Shattock R, Makatsoris C, Forbes B (2025a) Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology. Int J Pharm 672:125335. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125335","journal-title":"Int J Pharm"},{"key":"4596_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2025.113292","volume":"212","author":"T Li","year":"2025","unstructured":"Li T, Xiao L, Ling H, Yang Y, Zhong S (2025b) Preparation of artificial substrate binding sites of nanozyme with \u201cmodular structure\u201d strategy used for the construction of visual sensing analysis platform for levodopa. Microchem J 212:113292. https:\/\/doi.org\/10.1016\/j.microc.2025.113292","journal-title":"Microchem J"},{"key":"4596_CR157","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.vaccine.2019.04.094","volume":"37","author":"B Liang","year":"2019","unstructured":"Liang B, Li H, Li L, Omange RW, Hai Y, Luo M (2019) Current advances in HIV vaccine preclinical studies using Macaque models. Vaccine 37:3388\u20133399. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.094","journal-title":"Vaccine"},{"key":"4596_CR158","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mucimm.2023.01.002","volume":"16","author":"YS Lim","year":"2023","unstructured":"Lim YS, Shin H (2023) CD8 tissue-resident memory T cells bridge the gap between humoral and cell-mediated immunity. Mucosal Immunol 16:3\u20134. https:\/\/doi.org\/10.1016\/j.mucimm.2023.01.002","journal-title":"Mucosal Immunol"},{"issue":"47","key":"4596_CR159","doi-asserted-by":"publisher","first-page":"52691","DOI":"10.1021\/acsami.2c17627","volume":"14","author":"Y Lin","year":"2022","unstructured":"Lin Y, Sun B, Jin Z, Zhao K (2022) Enhanced immune responses to mucosa by functionalized chitosan-based composite nanoparticles as a vaccine adjuvant for intranasal delivery. ACS Appl Mater Interfaces 14(47):52691\u201352701. https:\/\/doi.org\/10.1021\/acsami.2c17627","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"4596_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16091159","volume":"16","author":"S Lindsay","year":"2024","unstructured":"Lindsay S, Tumolva O, Khamiakova T, Coppenolle H, Kovarik M, Shah S, Holm R, Perrie Y (2024) Can we simplify liposome manufacturing using a complex DoE approach? Pharmaceutics 16(9):1159. https:\/\/doi.org\/10.3390\/pharmaceutics16091159","journal-title":"Pharmaceutics"},{"key":"4596_CR161","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1126\/science.aag0491","volume":"353","author":"J Liu","year":"2016","unstructured":"Liu J, Ghneim K, Sok D, Bosche WJ, Li Y, Chipriano E et al (2016) Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus. Science 353:1045\u20131049. https:\/\/doi.org\/10.1126\/science.aag0491","journal-title":"Science"},{"key":"4596_CR162","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2022.03.021","volume":"345","author":"J-Q Liu","year":"2022","unstructured":"Liu J-Q, Zhang C, Zhang X, Yan J, Zeng C, Talebian F, Lynch K, Zhao W, Hou X, Du S, Kang DD, Deng B, McComb DW, Bai X-F, Dong Y (2022) Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy. J Control Release 345:306\u2013313. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.021","journal-title":"J Control Release"},{"key":"4596_CR163","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1038\/s41467-024-53914-x","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, Wen Y, Shan X, Ma X, Yang C, Cheng X et al (2024) Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination. Nat Commun 15:9471. https:\/\/doi.org\/10.1038\/s41467-024-53914-x","journal-title":"Nat Commun"},{"key":"4596_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118080","volume":"120","author":"C Liu","year":"2025","unstructured":"Liu C, Jiang Y, Xue W, Liu J, Wang Z, Li X (2025a) Janus dendritic ionizable lipids with fine designed headgroup and tails to improve mRNA delivery efficiency. Bioorg Med Chem 120:118080. https:\/\/doi.org\/10.1016\/j.bmc.2025.118080","journal-title":"Bioorg Med Chem"},{"key":"4596_CR165","doi-asserted-by":"publisher","DOI":"10.20517\/microstructures.2024.172","author":"X Liu","year":"2025","unstructured":"Liu X, Ji S, Cai Y, Yang F, You J, Luo L (2025) Advances in mRNA-LNP lung-targeted delivery strategies. Microstructures. https:\/\/doi.org\/10.20517\/microstructures.2024.172","journal-title":"Microstructures"},{"key":"4596_CR166","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/vaccines13030333","volume":"13","author":"W Liu","year":"2025","unstructured":"Liu W, Li Y, Li X, Wang F, Qi R, Zhu T et al (2025c) Pooled analysis of the effect of pre-existing Ad5 neutralizing antibodies on the immunogenicity of adenovirus type 5 vector-based COVID-19 vaccine from eight clinical trials. Vaccines 13:333. https:\/\/doi.org\/10.3390\/vaccines13030333","journal-title":"Vaccines"},{"issue":"3","key":"4596_CR167","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/acs.bioconjchem.7b00738","volume":"29","author":"S Longet","year":"2018","unstructured":"Longet S, Lundahl MLE, Lavelle EC (2018) Targeted strategies for mucosal vaccination. Bioconjug Chem 29(3):613\u2013623. https:\/\/doi.org\/10.1021\/acs.bioconjchem.7b00738","journal-title":"Bioconjug Chem"},{"issue":"9","key":"4596_CR168","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1039\/C5TB01753J","volume":"4","author":"KH Loomis","year":"2016","unstructured":"Loomis KH, Kirschman JL, Bhosle S, Bellamkonda RV, Santangelo PJ (2016) Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs. J Mater Chem B 4(9):1619\u20131632. https:\/\/doi.org\/10.1039\/C5TB01753J","journal-title":"J Mater Chem B"},{"issue":"9","key":"4596_CR169","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1021\/acs.bioconjchem.8b00443","volume":"29","author":"KH Loomis","year":"2018","unstructured":"Loomis KH, Lindsay KE, Zurla C, Bhosle SM, Vanover DA, Blanchard EL, Kirschman JL, Bellamkonda RV, Santangelo PJ (2018) In vitro transcribed mRNA vaccines with programmable stimulation of innate immunity. Bioconjug Chem 29(9):3072\u20133083. https:\/\/doi.org\/10.1021\/acs.bioconjchem.8b00443","journal-title":"Bioconjug Chem"},{"issue":"10","key":"4596_CR170","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/17425247.2022.2135502","volume":"19","author":"C Lopes","year":"2022","unstructured":"Lopes C, Crist\u00f3v\u00e3o J, Silv\u00e9rio V, Lino PR, Fonte P (2022) Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Expert Opin Drug Deliv 19(10):1381\u20131395. https:\/\/doi.org\/10.1080\/17425247.2022.2135502","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"4596_CR171","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-01080-z","volume":"31","author":"R-M Lu","year":"2024","unstructured":"Lu R-M, Hsu H-E, Perez SJLP, Kumari M, Chen G-H, Hong M-H, Lin Y-S, Liu C-H, Ko S-H, Concio CAP, Su Y-J, Chang Y-H, Li W-S, Wu H-C (2024) Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J Biomed Sci 31(1):89. https:\/\/doi.org\/10.1186\/s12929-024-01080-z","journal-title":"J Biomed Sci"},{"key":"4596_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101813","volume":"32","author":"Y Lu","year":"2025","unstructured":"Lu Y, Yang Y, Yi J, Hong X, Lou J, Li M, Zheng A (2025) Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination. Mater Today Bio 32:101813. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101813","journal-title":"Mater Today Bio"},{"issue":"10","key":"4596_CR173","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101187","volume":"9","author":"K Lundstrom","year":"2021","unstructured":"Lundstrom K (2021) Self-replicating RNA viruses for vaccine development against infectious diseases and cancer. Vaccines 9(10):1187. https:\/\/doi.org\/10.3390\/vaccines9101187","journal-title":"Vaccines"},{"key":"4596_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-025-02240-8","author":"S Luozhong","year":"2025","unstructured":"Luozhong S, Liu P, Li R, Yuan Z, Debley E, Chen Y et al (2025) Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity. Nat Mater. https:\/\/doi.org\/10.1038\/s41563-025-02240-8","journal-title":"Nat Mater"},{"key":"4596_CR175","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","volume":"16","author":"CJ Maine","year":"2025","unstructured":"Maine CJ, Miyake-Stoner SJ, Spasova DS, Picarda G, Chou AC, Brand ED et al (2025) Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers. Nat Commun 16:456. https:\/\/doi.org\/10.1038\/s41467-025-55843-9","journal-title":"Nat Commun"},{"issue":"8","key":"4596_CR176","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/17425247.2018.1503249","volume":"15","author":"RS Managuli","year":"2018","unstructured":"Managuli RS, Raut SY, Reddy MS, Mutalik S (2018) Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs. Expert Opin Drug Deliv 15(8):787\u2013804. https:\/\/doi.org\/10.1080\/17425247.2018.1503249","journal-title":"Expert Opin Drug Deliv"},{"issue":"11","key":"4596_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407383","volume":"12","author":"N Maniyamgama","year":"2025","unstructured":"Maniyamgama N, Bae KH, Chang ZW, Lee J, Ang MJY, Tan YJ, Ng LFP, Renia L, White KP, Yang YY (2025) Muco\u2010penetrating lipid nanoparticles having a liquid core for enhanced intranasal mRNA delivery. Adv Sci 12(11):2407383. https:\/\/doi.org\/10.1002\/advs.202407383","journal-title":"Adv Sci"},{"key":"4596_CR178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594470","volume":"11","author":"V Martini","year":"2020","unstructured":"Martini V, Hinchcliffe M, Blackshaw E, Joyce M, McNee A, Beverley P, Townsend A, MacLoughlin R, Tchilian E (2020) Distribution of droplets and immune responses after aerosol and intra-nasal delivery of influenza virus to the respiratory tract of pigs. Front Immunol 11:594470. https:\/\/doi.org\/10.3389\/fimmu.2020.594470","journal-title":"Front Immunol"},{"key":"4596_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106370","volume":"183","author":"M Massaro","year":"2023","unstructured":"Massaro M, Wu S, Baudo G, Liu H, Collum S, Lee H, Stigliano C, Segura-Ibarra V, Karmouty-Quintana H, Blanco E (2023) Lipid nanoparticle-mediated mRNA delivery in lung fibrosis. Eur J Pharm Sci 183:106370. https:\/\/doi.org\/10.1016\/j.ejps.2023.106370","journal-title":"Eur J Pharm Sci"},{"key":"4596_CR180","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1039\/D4PM00128A","volume":"1","author":"C McMillan","year":"2024","unstructured":"McMillan C, Druschitz A, Rumbelow S, Borah A, Binici B, Rattray Z et al (2024) Tailoring lipid nanoparticle dimensions through manufacturing processes. RSC Pharm 1:841\u2013853. https:\/\/doi.org\/10.1039\/D4PM00128A","journal-title":"RSC Pharm"},{"issue":"6","key":"4596_CR181","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W (2023) Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au 3(6):600\u2013619. https:\/\/doi.org\/10.1021\/acsmaterialsau.3c00032","journal-title":"ACS Mater Au"},{"issue":"9","key":"4596_CR182","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1039\/C9BM00759H","volume":"7","author":"M Melo","year":"2019","unstructured":"Melo M, Nunes R, Sarmento B, Das Neves J (2019) Colorectal distribution and retention of polymeric nanoparticles following incorporation into a thermosensitive enema. Biomater Sci 7(9):3801\u20133811. https:\/\/doi.org\/10.1039\/C9BM00759H","journal-title":"Biomater Sci"},{"key":"4596_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113900","volume":"176","author":"A-K Minnaert","year":"2021","unstructured":"Minnaert A-K, Vanluchene H, Verbeke R, Lentacker I, De Smedt SC, Raemdonck K, Sanders NN, Remaut K (2021) Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across. Adv Drug Deliv Rev 176:113900. https:\/\/doi.org\/10.1016\/j.addr.2021.113900","journal-title":"Adv Drug Deliv Rev"},{"key":"4596_CR184","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature01726","volume":"424","author":"JR Mora","year":"2003","unstructured":"Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M et al (2003) Selective imprinting of gut-homing T cells by Peyer\u2019s patch dendritic cells. Nature 424:88\u201393. https:\/\/doi.org\/10.1038\/nature01726","journal-title":"Nature"},{"key":"4596_CR185","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev.iy.12.040194.000431","volume":"12","author":"KE Mostov","year":"1994","unstructured":"Mostov KE (1994) Transepithelial transport of immunoglobulins. Annu Rev Immunol 12:63\u201384. https:\/\/doi.org\/10.1146\/annurev.iy.12.040194.000431","journal-title":"Annu Rev Immunol"},{"key":"4596_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2021.112601","volume":"133","author":"M Munir","year":"2022","unstructured":"Munir M, Jena L, Kett VL, Dunne NJ, McCarthy HO (2022) Spray drying: inhalable powders for pulmonary gene therapy. Biomater Adv 133:112601. https:\/\/doi.org\/10.1016\/j.msec.2021.112601","journal-title":"Biomater Adv"},{"issue":"5","key":"4596_CR187","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ymthe.2022.02.001","volume":"30","author":"H Muramatsu","year":"2022","unstructured":"Muramatsu H, Lam K, Bajusz C, Laczk\u00f3 D, Karik\u00f3 K, Schreiner P, Martin A, Lutwyche P, Heyes J, Pardi N (2022) Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. Mol Ther 30(5):1941\u20131951. https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.001","journal-title":"Mol Ther"},{"key":"4596_CR188","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01225-20","volume":"94","author":"T Musich","year":"2020","unstructured":"Musich T, Thovarai V, Venzon DJ, Mohanram V, Tuero I, Miller-Novak LK et al (2020) A prime\/boost vaccine regimen alters the rectal microbiome and impacts immune responses and viremia control post-simian immunodeficiency virus infection in male and female rhesus macaques. J Virol 94:e01225-20. https:\/\/doi.org\/10.1128\/JVI.01225-20","journal-title":"J Virol"},{"key":"4596_CR189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274829","volume":"17","author":"A Nakamura","year":"2022","unstructured":"Nakamura A, Kotaki T, Nagai Y, Takazawa S, Tokunaga K, Kameoka M (2022) Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon. PLoS One 17:e0274829. https:\/\/doi.org\/10.1371\/journal.pone.0274829","journal-title":"PLoS One"},{"key":"4596_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103479","volume":"24","author":"S Ndeupen","year":"2021","unstructured":"Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igy\u00e1rt\u00f3 BZ (2021a) The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience 24:103479. https:\/\/doi.org\/10.1016\/j.isci.2021.103479","journal-title":"iScience"},{"key":"4596_CR191","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.04.430128","author":"S Ndeupen","year":"2021","unstructured":"Ndeupen S, Qin Z, Jacobsen S, Estanbouli H, Bouteau A, Igy\u00e1rt\u00f3 BZ (2021) The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory [Internet]. Immunology. https:\/\/doi.org\/10.1101\/2021.03.04.430128","journal-title":"Immunology"},{"key":"4596_CR192","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/pharmaceutics12040321","volume":"12","author":"F Notario-P\u00e9rez","year":"2020","unstructured":"Notario-P\u00e9rez F, Mart\u00edn-Illana A, Cazorla-Luna R, Ruiz-Caro R, Tamayo A, Rubio J et al (2020) Mucoadhesive vaginal discs based on cyclodextrin and surfactants for the controlled release of antiretroviral drugs to prevent the sexual transmission of HIV. Pharmaceutics 12:321. https:\/\/doi.org\/10.3390\/pharmaceutics12040321","journal-title":"Pharmaceutics"},{"key":"4596_CR194","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124632","volume":"665","author":"K Ogawa","year":"2024","unstructured":"Ogawa K, Aikawa O, Tagami T, Ito T, Tahara K, Kawakami S, Ozeki T (2024) Stable and inhalable powder formulation of mRNA-LNPs using pH-modified spray-freeze drying. Int J Pharm 665:124632. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124632","journal-title":"Int J Pharm"},{"key":"4596_CR195","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj5129","volume":"6","author":"JE Oh","year":"2021","unstructured":"Oh JE, Song E, Moriyama M, Wong P, Zhang S, Jiang R et al (2021) Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA. Sci Immunol 6:eabj5129. https:\/\/doi.org\/10.1126\/sciimmunol.abj5129","journal-title":"Sci Immunol"},{"key":"4596_CR196","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jconrel.2022.06.017","volume":"348","author":"K Okuda","year":"2022","unstructured":"Okuda K, Sato Y, Iwakawa K, Sasaki K, Okabe N, Maeki M, Tokeshi M, Harashima H (2022) On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic device. J Control Release 348:648\u2013659. https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.017","journal-title":"J Control Release"},{"key":"4596_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114266","volume":"198","author":"M Ongun","year":"2024","unstructured":"Ongun M, Lokras AG, Baghel S, Shi Z, Schmidt ST, Franzyk H, Rades T, Sebastiani F, Thakur A, Foged C (2024) Lipid nanoparticles for local delivery of mRNA to the respiratory tract: effect of PEG-lipid content and administration route. Eur J Pharm Biopharm 198:114266. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114266","journal-title":"Eur J Pharm Biopharm"},{"key":"4596_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-3659(01)00545-4","volume":"79","author":"G Ott","year":"2002","unstructured":"Ott G (2002) A cationic sub-micron emulsion (MF59\/DOTAP) is an effective delivery system for DNA vaccines. J Controlled Release 79:1\u20135. https:\/\/doi.org\/10.1016\/S0168-3659(01)00545-4","journal-title":"J Controlled Release"},{"issue":"3","key":"4596_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102654","volume":"36","author":"A Pandey","year":"2025","unstructured":"Pandey A, Kumar S, Mishra S (2025) Intranasal mRNA vaccines: targeting mucosal immunity through optimized delivery. Mol Ther Nucleic Acids 36(3):102654. https:\/\/doi.org\/10.1016\/j.omtn.2025.102654","journal-title":"Mol Ther Nucleic Acids"},{"key":"4596_CR200","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jconrel.2021.03.017","volume":"332","author":"AL Paris","year":"2021","unstructured":"Paris AL, Colomb E, Verrier B, Anju\u00e8re F, Monge C (2021) Sublingual vaccination and delivery systems. J Control Release 332:553\u2013562. https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.017","journal-title":"J Control Release"},{"key":"4596_CR201","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.actbio.2018.08.005","volume":"78","author":"C Pereira Gomes","year":"2018","unstructured":"Pereira Gomes C, Leiro V, Ferreira Lopes CD, Spencer AP, P\u00eago AP (2018) Fine tuning neuronal targeting of nanoparticles by adjusting the ligand grafting density and combining PEG spacers of different length. Acta Biomater 78:247\u2013259. https:\/\/doi.org\/10.1016\/j.actbio.2018.08.005","journal-title":"Acta Biomater"},{"issue":"4","key":"4596_CR202","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126047","volume":"4","author":"C Petitdemange","year":"2019","unstructured":"Petitdemange C, Kasturi SP, Kozlowski PA, Nabi R, Quarnstrom CF, Reddy PBJ, Derdeyn CA, Spicer LM, Patel P, Legere T, Kovalenkov YO, Labranche CC, Villinger F, Tomai M, Vasilakos J, Haynes B, Kang CY, Gibbs JS, Yewdell JW, Barouch D, Wrammert J, Montefiori D, Hunter E, Amara RR, Masopust D, Pulendran B (2019) Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques. JCI Insight 4(4):e126047. https:\/\/doi.org\/10.1172\/jci.insight.126047","journal-title":"JCI Insight"},{"key":"4596_CR203","doi-asserted-by":"publisher","first-page":"51697","DOI":"10.1021\/acsami.2c14670","volume":"14","author":"T Pho","year":"2022","unstructured":"Pho T, Champion JA (2022) Surface engineering of protein nanoparticles modulates transport, adsorption, and uptake in mucus. ACS Appl Mater Interfaces 14:51697\u201351710. https:\/\/doi.org\/10.1021\/acsami.2c14670","journal-title":"ACS Appl Mater Interfaces"},{"issue":"01","key":"4596_CR204","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1055\/a-1577-2955","volume":"72","author":"B Prasaja","year":"2022","unstructured":"Prasaja B, Harahap Y, Sandra M, Iskandar I, Lusthom W, Cahyaningsih P (2022) Rectal administration of ibuprofen: comparison of enema and suppository form. Drug Res 72(01):18\u201322. https:\/\/doi.org\/10.1055\/a-1577-2955","journal-title":"Drug Res"},{"key":"4596_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122874","volume":"637","author":"A Pratsinis","year":"2023","unstructured":"Pratsinis A, Fan Y, Portmann M, Hammel M, Kou P, Sarode A, Ringler P, Kovacik L, Lauer ME, Lamerz J, Hura GL, Yen C-W, Keller M (2023) Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations. Int J Pharm 637:122874. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122874","journal-title":"Int J Pharm"},{"key":"4596_CR206","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41541-023-00677-z","volume":"8","author":"JT Prior","year":"2023","unstructured":"Prior JT, Limbert VM, Horowitz RM, D\u2019Souza SJ, Bachnak L, Godwin MS et al (2023) Establishment of isotype-switched, antigen-specific B cells in multiple mucosal tissues using non-mucosal immunization. NPJ Vaccines 8:80. https:\/\/doi.org\/10.1038\/s41541-023-00677-z","journal-title":"NPJ Vaccines"},{"issue":"1","key":"4596_CR207","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-017-0167-6","volume":"14","author":"JL Prodger","year":"2017","unstructured":"Prodger JL, Kaul R (2017) The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field. AIDS Res Ther 14(1):49. https:\/\/doi.org\/10.1186\/s12981-017-0167-6","journal-title":"AIDS Res Ther"},{"key":"4596_CR208","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811924-2.00045-6","author":"B Pulendran","year":"2020","unstructured":"Pulendran B (2020) Systems biological approaches for mucosal vaccine development. Mucosal Vaccines. https:\/\/doi.org\/10.1016\/B978-0-12-811924-2.00045-6","journal-title":"Mucosal Vaccines"},{"key":"4596_CR210","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012714","volume":"20","author":"AG Rader","year":"2024","unstructured":"Rader AG, Cloherty APM, Patel KS, Almandawi DDA, Pajkrt D, Wolthers KC et al (2024) HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa. PLoS Pathog 20:e1012714. https:\/\/doi.org\/10.1371\/journal.ppat.1012714","journal-title":"PLoS Pathog"},{"key":"4596_CR211","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1038\/s41467-022-31005-z","volume":"13","author":"AR Rappaport","year":"2022","unstructured":"Rappaport AR, Hong S-J, Scallan CD, Gitlin L, Akoopie A, Boucher GR et al (2022) Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against SARS-CoV-2 infection. Nat Commun 13:3289. https:\/\/doi.org\/10.1038\/s41467-022-31005-z","journal-title":"Nat Commun"},{"key":"4596_CR212","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jconrel.2022.10.059","volume":"352","author":"M Rawas-Qalaji","year":"2022","unstructured":"Rawas-Qalaji M, Thu HE, Hussain Z (2022) Oromucosal delivery of macromolecules: challenges and recent developments to improve bioavailability. J Control Release 352:726\u2013746. https:\/\/doi.org\/10.1016\/j.jconrel.2022.10.059","journal-title":"J Control Release"},{"key":"4596_CR213","doi-asserted-by":"publisher","unstructured":"Richards AF, Torres-Velez FJ, Mantis NJ. Salmonella Uptake into Gut-Associated Lymphoid Tissues: Implications for Targeted Mucosal Vaccine Design and Delivery. In: Thomas S, editor. Vaccine Des [Internet]. New York, NY: Springer US; 2022 [cited 2025 Aug 30]. p. 305\u201324. https:\/\/doi.org\/10.1007\/978-1-0716-1884-4_15","DOI":"10.1007\/978-1-0716-1884-4_15"},{"key":"4596_CR214","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K R\u00f6ltgen","year":"2022","unstructured":"R\u00f6ltgen K, Nielsen SCA, Silva O, Younes SF, Zaslavsky M, Costales C et al (2022) Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185:1025-1040.e14. https:\/\/doi.org\/10.1016\/j.cell.2022.01.018","journal-title":"Cell"},{"key":"4596_CR215","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.11.642674","author":"JE Rood","year":"2025","unstructured":"Rood JE, Yoon SK, Heard MK, Carro SD, Hedgepeth EJ, O\u2019Mara ME et al (2025) Endogenous antigen processing promotes mRNA vaccine CD4+ T cell responses [Internet]. Immunology. https:\/\/doi.org\/10.1101\/2025.03.11.642674","journal-title":"Immunology"},{"issue":"16","key":"4596_CR216","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"SS Rosa","year":"2021","unstructured":"Rosa SS, Prazeres DMF, Azevedo AM, Marques MPC (2021) mRNA vaccines manufacturing: challenges and bottlenecks. Vaccine 39(16):2190\u20132200. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.038","journal-title":"Vaccine"},{"key":"4596_CR217","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jconrel.2017.12.003","volume":"271","author":"F Rose","year":"2018","unstructured":"Rose F, Wern JE, Gavins F, Andersen P, Follmann F, Foged C (2018) A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522. J Control Release 271:88\u201397. https:\/\/doi.org\/10.1016\/j.jconrel.2017.12.003","journal-title":"J Control Release"},{"key":"4596_CR218","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/vaccines7040194","volume":"7","author":"RM Ruprecht","year":"2019","unstructured":"Ruprecht RM, Marasini B, Thippeshappa R (2019) Mucosal antibodies: defending epithelial barriers against HIV-1 invasion. Vaccines 7:194. https:\/\/doi.org\/10.3390\/vaccines7040194","journal-title":"Vaccines"},{"key":"4596_CR219","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","volume":"13","author":"K Sano","year":"2022","unstructured":"Sano K, Bhavsar D, Singh G, Floda D, Srivastava K, Gleason C et al (2022) SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat Commun 13:5135. https:\/\/doi.org\/10.1038\/s41467-022-32389-8","journal-title":"Nat Commun"},{"key":"4596_CR220","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66669","author":"KR Santhanakrishnan","year":"2024","unstructured":"Santhanakrishnan KR, Koilpillai J, Narayanasamy D (2024) PEGylation in pharmaceutical development: current status and emerging trends in macromolecular and immunotherapeutic drugs. Cureus. https:\/\/doi.org\/10.7759\/cureus.66669","journal-title":"Cureus"},{"key":"4596_CR221","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab191","author":"B Sapkota","year":"2021","unstructured":"Sapkota B, Saud B, Shrestha R, Al-Fahad D, Sah R, Shrestha S et al (2021) Heterologous prime\u2013boost strategies for COVID-19 vaccines. J Travel Med. https:\/\/doi.org\/10.1093\/jtm\/taab191","journal-title":"J Travel Med"},{"key":"4596_CR222","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/pharmaceutics14081572","volume":"14","author":"K Sasaki","year":"2022","unstructured":"Sasaki K, Sato Y, Okuda K, Iwakawa K, Harashima H (2022) mRNA-loaded lipid nanoparticles targeting dendritic cells for cancer immunotherapy. Pharmaceutics 14:1572. https:\/\/doi.org\/10.3390\/pharmaceutics14081572","journal-title":"Pharmaceutics"},{"key":"4596_CR223","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/vaccines10101694","volume":"10","author":"F Sato-Kaneko","year":"2022","unstructured":"Sato-Kaneko F, Yao S, Lao FS, Sako Y, Jin J, Shukla NM et al (2022) A dual adjuvant system for intranasal boosting of local and systemic immunity for influenza vaccination. Vaccines 10:1694. https:\/\/doi.org\/10.3390\/vaccines10101694","journal-title":"Vaccines"},{"key":"4596_CR224","doi-asserted-by":"publisher","first-page":"377","DOI":"10.18609\/cgti.2022.056","volume":"08","author":"NA Schmidt","year":"2022","unstructured":"Schmidt NA, MacLachlan TK, Dandapat S, Veres G, Reimer TA, Schulz M et al (2022) Current global regulatory landscape for biodistribution & shedding assessment of rAAV gene therapies & recommendations of the IMI ARDAT consortium on future directions. Cell Gene Ther Insights 08:377\u2013394. https:\/\/doi.org\/10.18609\/cgti.2022.056","journal-title":"Cell Gene Ther Insights"},{"key":"4596_CR225","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41541-021-00305-8","volume":"6","author":"KE Seaton","year":"2021","unstructured":"Seaton KE, Deal A, Han X, Li SS, Clayton A, Heptinstall J et al (2021) Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans. Npj Vaccines 6:56. https:\/\/doi.org\/10.1038\/s41541-021-00305-8","journal-title":"Npj Vaccines"},{"issue":"2","key":"4596_CR226","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020359","volume":"15","author":"A Seifelnasr","year":"2023","unstructured":"Seifelnasr A, Talaat M, Ramaswamy P, Si XA, Xi J (2023) A supine position and dual-dose applications enhance spray dosing to the posterior nose: paving the way for mucosal immunization. Pharmaceutics 15(2):359. https:\/\/doi.org\/10.3390\/pharmaceutics15020359","journal-title":"Pharmaceutics"},{"issue":"2","key":"4596_CR227","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/mi.2016.62","volume":"10","author":"L Shang","year":"2017","unstructured":"Shang L, Duan L, Perkey KE, Wietgrefe S, Zupancic M, Smith AJ, Southern PJ, Johnson RP, Haase AT (2017) Epithelium-innate immune cell axis in mucosal responses to SIV. Mucosal Immunol 10(2):508\u2013519. https:\/\/doi.org\/10.1038\/mi.2016.62","journal-title":"Mucosal Immunol"},{"key":"4596_CR228","doi-asserted-by":"publisher","first-page":"940","DOI":"10.6363\/jpehss.v3i2.460","volume":"3","author":"Z Sharif","year":"2025","unstructured":"Sharif Z, Shah S, Babur MN, Razzaq S, Sarwar A (2025) Emerging vaccine technologies against cytomegalovirus: a narrative review of viral vectors, DNA, and mRNA-based strategies. Phys Educ Health Soc Sci 3:940\u201352. https:\/\/doi.org\/10.6363\/jpehss.v3i2.460","journal-title":"Phys Educ Health Soc Sci"},{"key":"4596_CR229","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","volume":"15","author":"S Sheikh-Mohamed","year":"2022","unstructured":"Sheikh-Mohamed S, Isho B, Chao GYC, Zuo M, Cohen C, Lustig Y et al (2022) Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection. Mucosal Immunol 15:799\u2013808. https:\/\/doi.org\/10.1038\/s41385-022-00511-0","journal-title":"Mucosal Immunol"},{"issue":"1","key":"4596_CR230","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11904-021-00597-4","volume":"19","author":"BO Shepherd","year":"2022","unstructured":"Shepherd BO, Chang D, Vasan S, Ake J, Modjarrad K (2022) HIV and SARS-CoV-2: tracing a path of vaccine research and development. Curr HIV AIDS Rep 19(1):86\u201393. https:\/\/doi.org\/10.1007\/s11904-021-00597-4","journal-title":"Curr HIV AIDS Rep"},{"issue":"12","key":"4596_CR231","doi-asserted-by":"publisher","DOI":"10.3390\/md18120605","volume":"18","author":"S Shim","year":"2020","unstructured":"Shim S, Yoo HS (2020) The application of mucoadhesive chitosan nanoparticles in nasal drug delivery. Mar Drugs 18(12):605. https:\/\/doi.org\/10.3390\/md18120605","journal-title":"Mar Drugs"},{"key":"4596_CR232","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1248\/yakushi.19-00187-5","volume":"140","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Ishima Y, Ishida T (2020) Induction of anti-PEG immune responses by PEGylation of proteins. Yakugaku Zasshi 140:163\u2013169. https:\/\/doi.org\/10.1248\/yakushi.19-00187-5","journal-title":"Yakugaku Zasshi"},{"key":"4596_CR233","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.actbio.2021.12.015","volume":"140","author":"N Shrestha","year":"2022","unstructured":"Shrestha N, Xu Y, Pr\u00e9vost JRC, McCartney F, Brayden D, Fr\u00e9d\u00e9rick R, Beloqui A, Pr\u00e9at V (2022) Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease. Acta Biomater 140:561\u2013572. https:\/\/doi.org\/10.1016\/j.actbio.2021.12.015","journal-title":"Acta Biomater"},{"key":"4596_CR234","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni.f.208","volume":"9","author":"H Sigmundsdottir","year":"2008","unstructured":"Sigmundsdottir H, Butcher EC (2008) Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 9:981\u2013987. https:\/\/doi.org\/10.1038\/ni.f.208","journal-title":"Nat Immunol"},{"key":"4596_CR235","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/vaccines12030318","volume":"12","author":"N Silva-Pilipich","year":"2024","unstructured":"Silva-Pilipich N, Beloki U, Salaberry L, Smerdou C (2024) Self-amplifying RNA: a second revolution of mRNA vaccines against COVID-19. Vaccines 12:318. https:\/\/doi.org\/10.3390\/vaccines12030318","journal-title":"Vaccines"},{"key":"4596_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118592","volume":"569","author":"G Sinani","year":"2019","unstructured":"Sinani G, Sessevmez M, G\u00f6k MK, \u00d6zg\u00fcm\u00fc\u015f S, Alpar HO, Cevher E (2019) Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination. Int J Pharm 569:118592. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118592","journal-title":"Int J Pharm"},{"key":"4596_CR237","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.983000","volume":"13","author":"C Sittplangkoon","year":"2022","unstructured":"Sittplangkoon C, Alameh M-G, Weissman D, Lin PJC, Tam YK, Prompetchara E, Palaga T (2022) mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model. Front Immunol 13:983000. https:\/\/doi.org\/10.3389\/fimmu.2022.983000","journal-title":"Front Immunol"},{"key":"4596_CR238","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121386","volume":"12","author":"JC Smith","year":"2024","unstructured":"Smith JC, Arunachalam PS, Legere TH, Cavacini LA, Hunter E, Pulendran B et al (2024) Induction of tier 2 HIV-neutralizing IgA antibodies in rhesus macaques vaccinated with BG505.664 SOSIP. Vaccines 12:1386. https:\/\/doi.org\/10.3390\/vaccines12121386","journal-title":"Vaccines"},{"key":"4596_CR239","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.smim.2017.07.007","volume":"30","author":"U Smole","year":"2017","unstructured":"Smole U, Schabussova I, Pickl WF, Wiedermann U (2017) Murine models for mucosal tolerance in allergy. Semin Immunol 30:12\u201327. https:\/\/doi.org\/10.1016\/j.smim.2017.07.007","journal-title":"Semin Immunol"},{"issue":"4","key":"4596_CR240","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.xphs.2019.12.020","volume":"109","author":"OY Soliman","year":"2020","unstructured":"Soliman OY, Alameh MG, De Cresenzo G, Buschmann MD, Lavertu M (2020) Efficiency of chitosan\/hyaluronan-based mRNA delivery systems in vitro: influence of composition and structure. J Pharm Sci 109(4):1581\u20131593. https:\/\/doi.org\/10.1016\/j.xphs.2019.12.020","journal-title":"J Pharm Sci"},{"key":"4596_CR241","doi-asserted-by":"publisher","unstructured":"Song SD, Acharya KD, Zhu JE, Deveney CM, Walther-Antonio MRS, Tetel MJ, et al. (2020) Daily Vaginal Microbiota Fluctuations Associated with Natural Hormonal Cycle, Contraceptives, Diet, and Exercise. Rao K, editor. mSphere. https:\/\/doi.org\/10.1128\/msphere.00593-20","DOI":"10.1128\/msphere.00593-20"},{"key":"4596_CR03","doi-asserted-by":"publisher","unstructured":"Song Y, Huang Y, Zhou F, Ding J, Zhou W (2022) Macrophage-targeted nanomedicine \u200efor chronic diseases immunotherapy. Chin Chem Lett 33(2):597\u2013612. https:\/\/doi.org\/10.1016\/j.cclet.2021.08.090","DOI":"10.1016\/j.cclet.2021.08.090"},{"key":"4596_CR242","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.07.442971","author":"A Ssemaganda","year":"2021","unstructured":"Ssemaganda A, Nguyen HM, Nuhu F, Jahan N, Card CM, Kiazyk S et al (2021) Expansion of tissue-resident CD8+ T cells and CD4+ Th17 cells in the nasal mucosa following mRNA COVID-19 vaccination [Internet]. Immunology. https:\/\/doi.org\/10.1101\/2021.05.07.442971","journal-title":"Immunology"},{"issue":"1","key":"4596_CR243","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-014-0078-8","volume":"11","author":"DJ Stieh","year":"2014","unstructured":"Stieh DJ, King DF, Klein K, Liu P, Shen X, Hwang KK, Ferrari G, Montefiori DC, Haynes B, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Michael NL, Robb ML, Kim JH, Denny TN, Tomaras GD, Shattock RJ (2014) Aggregate complexes of HIV-1 induced by multimeric antibodies. Retrovirology 11(1):78. https:\/\/doi.org\/10.1186\/s12977-014-0078-8","journal-title":"Retrovirology"},{"issue":"8_Supplement_1","key":"4596_CR244","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2025-474","volume":"85","author":"L Strauss","year":"2025","unstructured":"Strauss L, Burns CJ, Inagaki A, Lees S, Kasahara N, Roh C, Johnson RG (2025) Abstract 474: IL-12 immunotherapy using a novel gene delivery platform for RNA payloads achieves effective antitumor responses without systemic toxicity in an aggressive CT26 murine cancer model. Cancer Res 85(8_Supplement_1):474\u2013474. https:\/\/doi.org\/10.1158\/1538-7445.AM2025-474","journal-title":"Cancer Res"},{"key":"4596_CR245","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2020v12i6.39565","author":"MAP Sudheer","year":"2020","unstructured":"Sudheer MAP, Sogali BS (2020) Custom design perspective in the process parameter optimization of nano lipid carriers. Int J Appl Pharm. https:\/\/doi.org\/10.22159\/ijap.2020v12i6.39565","journal-title":"Int J Appl Pharm"},{"issue":"3","key":"4596_CR246","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1172\/JCI122110","volume":"129","author":"Y Sui","year":"2019","unstructured":"Sui Y, Lewis GK, Wang Y, Berckmueller K, Frey B, Dzutsev A, Vargas-Inchaustegui D, Mohanram V, Musich T, Shen X, DeVico A, Fouts T, Venzon D, Kirk J, Waters RC, Talton J, Klinman D, Clements J, Tomaras GD, Franchini G, Robert-Guroff M, Trinchieri G, Gallo RC, Berzofsky JA (2019) Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response. J Clin Invest 129(3):1314\u20131328. https:\/\/doi.org\/10.1172\/JCI122110","journal-title":"J Clin Invest"},{"key":"4596_CR247","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.30.644708","author":"Z Sun","year":"2025","unstructured":"Sun Z, Liu Y, Zhang H, Ge T, Pan Y, Liu Y et al (2025) Next-Generation saRNA platforms: systematic screening and engineering enhances superior protein expression and organ-specific targeting for RNA therapeutics [Internet]. Mole Biol. https:\/\/doi.org\/10.1101\/2025.03.30.644708","journal-title":"Mole Biol"},{"key":"4596_CR248","doi-asserted-by":"publisher","first-page":"6224","DOI":"10.1038\/s41467-023-41966-4","volume":"14","author":"K Suphaphiphat","year":"2023","unstructured":"Suphaphiphat K, Desjardins D, Lorin V, Dimant N, Bouchemal K, Bossevot L et al (2023) Mucosal application of the broadly neutralizing antibody 10\u20131074 protects macaques from cell-associated SHIV vaginal exposure. Nat Commun 14:6224. https:\/\/doi.org\/10.1038\/s41467-023-41966-4","journal-title":"Nat Commun"},{"issue":"5","key":"4596_CR249","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s13346-024-01709-4","volume":"15","author":"K Suri","year":"2025","unstructured":"Suri K, Pfeifer L, Cvet D, Li A, McCoy M, Singh A, Amiji MM (2025) Oral delivery of stabilized lipid nanoparticles for nucleic acid therapeutics. Drug Deliv Transl Res 15(5):1755\u20131769. https:\/\/doi.org\/10.1007\/s13346-024-01709-4","journal-title":"Drug Deliv Transl Res"},{"key":"4596_CR250","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119792","volume":"588","author":"T Suzuki","year":"2020","unstructured":"Suzuki T, Suzuki Y, Hihara T, Kubara K, Kondo K, Hyodo K, Yamazaki K, Ishida T, Ishihara H (2020) PEG shedding-rate-dependent blood clearance of PEGylated lipid nanoparticles in mice: faster PEG shedding attenuates anti-PEG IgM production. Int J Pharm 588:119792. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119792","journal-title":"Int J Pharm"},{"issue":"18","key":"4596_CR251","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304525","volume":"13","author":"B Tafech","year":"2024","unstructured":"Tafech B, Rokhforouz M, Leung J, Sung MM, Lin PJ, Sin DD, Lauster D, Block S, Quon BS, Tam Y, Cullis P, Feng JJ, Hedtrich S (2024) Exploring mechanisms of lipid nanoparticle\u2010mucus interactions in healthy and cystic fibrosis conditions. Adv Healthc Mater 13(18):2304525. https:\/\/doi.org\/10.1002\/adhm.202304525","journal-title":"Adv Healthc Mater"},{"key":"4596_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106234","volume":"176","author":"A Tam","year":"2022","unstructured":"Tam A, Kulkarni J, An K, Li L, Dorscheid D, Singhera G, Dorscheid DR, Singhera GK, Bernatchez P, Reid GSD, Chan KYT, Witzigmann D, Cullis PR, Sin DD, Lim CJ (2022) Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. Eur J Pharm Sci 176:106234. https:\/\/doi.org\/10.1016\/j.ejps.2022.106234","journal-title":"Eur J Pharm Sci"},{"key":"4596_CR253","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/mi.2017.89","volume":"11","author":"H-X Tan","year":"2018","unstructured":"Tan H-X, Wheatley AK, Esterbauer R, Jegaskanda S, Glass JJ, Masopust D et al (2018) Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime\u2013boost immunization. Mucosal Immunol 11:994\u20131007. https:\/\/doi.org\/10.1038\/mi.2017.89","journal-title":"Mucosal Immunol"},{"key":"4596_CR254","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009632","volume":"17","author":"RA Taylor","year":"2021","unstructured":"Taylor RA, Xiao S, Carias AM, McRaven MD, Thakkar DN, Ara\u00ednga M et al (2021) PET\/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposure. PLoS Pathog 17:e1009632. https:\/\/doi.org\/10.1371\/journal.ppat.1009632","journal-title":"PLoS Pathog"},{"key":"4596_CR255","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157016212799304689","volume":"10","author":"D Tebit","year":"2012","unstructured":"Tebit D, Ndembi N, Weinberg A, Quinones-Mateu M (2012) Mucosal transmission of human immunodeficiency virus. Curr HIV Res 10:3\u20138. https:\/\/doi.org\/10.2174\/157016212799304689","journal-title":"Curr HIV Res"},{"key":"4596_CR256","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/vaccines8040779","volume":"8","author":"JG Tell","year":"2020","unstructured":"Tell JG, Coller B-AG, Dubey SA, Jenal U, Lapps W, Wang L et al (2020) Environmental risk assessment for rVSV\u0394G-ZEBOV-GP, a genetically modified live vaccine for ebola virus disease. Vaccines 8:779. https:\/\/doi.org\/10.3390\/vaccines8040779","journal-title":"Vaccines"},{"issue":"11","key":"4596_CR257","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4161\/21645515.2014.990859","volume":"2015","author":"AA Timothy","year":"2015","unstructured":"Timothy AA, Tokanovic A, Snibson KJ, Edwards SJ, Pearse MJ, Scheerlinck J-PY et al (2015) ISCOMATRIXTM adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza. Hum Vaccines Immunother 2015(11):377\u201385. https:\/\/doi.org\/10.4161\/21645515.2014.990859","journal-title":"Hum Vaccines Immunother"},{"key":"4596_CR258","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/vaccines12060670","volume":"12","author":"A Toniolo","year":"2024","unstructured":"Toniolo A, Maccari G, Camussi G (2024) mRNA technology and mucosal immunization. Vaccines 12:670. https:\/\/doi.org\/10.3390\/vaccines12060670","journal-title":"Vaccines"},{"issue":"2","key":"4596_CR259","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020266","volume":"20","author":"MG Torcia","year":"2019","unstructured":"Torcia MG (2019) Interplay among vaginal microbiome, immune response and sexually transmitted viral infections. Int J Mol Sci 20(2):266. https:\/\/doi.org\/10.3390\/ijms20020266","journal-title":"Int J Mol Sci"},{"key":"4596_CR260","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/vaccines9101177","volume":"9","author":"V Trincado","year":"2021","unstructured":"Trincado V, Gala RP, Morales JO (2021) Buccal and sublingual vaccines: a review on oral mucosal immunization and delivery systems. Vaccines 9:1177. https:\/\/doi.org\/10.3390\/vaccines9101177","journal-title":"Vaccines"},{"key":"4596_CR261","doi-asserted-by":"publisher","first-page":"e35334","DOI":"10.1016\/j.heliyon.2024.e35334","volume":"10","author":"H-W Tsoi","year":"2024","unstructured":"Tsoi H-W, Ng MK-W, Cai J-P, Poon RW-S, Chan BP-C, Chan K-H et al (2024) The impact of vaccine type and booster dose on the magnitude and breadth of SARS-CoV-2-specific systemic and mucosal antibodies among COVID-19 vaccine recipients. Heliyon 10:e35334. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35334","journal-title":"Heliyon"},{"key":"4596_CR262","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-025-01958-5","author":"M Vadovics","year":"2025","unstructured":"Vadovics M, Zhao W, Daley EF, Lam K, Daly O, Rashid K et al (2025) Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications. Nat Nanotechnol. https:\/\/doi.org\/10.1038\/s41565-025-01958-5","journal-title":"Nat Nanotechnol"},{"key":"4596_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103162","volume":"70","author":"B Valamla","year":"2022","unstructured":"Valamla B, Thakor P, Phuse R, Dalvi M, Kharat P, Kumar A, Panwar D, Singh SB, Giorgia P, Mehra NK (2022) Engineering drug delivery systems to overcome the vaginal mucosal barrier: current understanding and research agenda of mucoadhesive formulations of vaginal delivery. J Drug Deliv Sci Technol 70:103162. https:\/\/doi.org\/10.1016\/j.jddst.2022.103162","journal-title":"J Drug Deliv Sci Technol"},{"key":"4596_CR264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9010001","volume":"9","author":"H Van Der Weken","year":"2020","unstructured":"Van Der Weken H, Cox E, Devriendt B (2020) Advances in oral subunit vaccine design. Vaccines 9:1. https:\/\/doi.org\/10.3390\/vaccines9010001","journal-title":"Vaccines"},{"key":"4596_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113956","volume":"178","author":"HM VanBenschoten","year":"2021","unstructured":"VanBenschoten HM, Woodrow KA (2021) Vaginal delivery of vaccines. Adv Drug Deliv Rev 178:113956. https:\/\/doi.org\/10.1016\/j.addr.2021.113956","journal-title":"Adv Drug Deliv Rev"},{"key":"4596_CR266","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v94i1.13738","volume":"94","author":"A Varricchio","year":"2023","unstructured":"Varricchio A, Brunese F, La Mantia I, Ascione E, Ciprandi G (2023) Choosing nasal devices: a dilemma in clinical practice. Acta Biomed Atenei Parm 94:e2023034. https:\/\/doi.org\/10.23750\/abm.v94i1.13738","journal-title":"Acta Biomed Atenei Parm"},{"key":"4596_CR267","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708355","volume":"12","author":"RT Veenhuis","year":"2021","unstructured":"Veenhuis RT, Garliss CC, Bailey JR, Blankson JN (2021) CD8 effector T cells function synergistically with broadly neutralizing antibodies to enhance suppression of HIV infection. Front Immunol 12:708355. https:\/\/doi.org\/10.3389\/fimmu.2021.708355","journal-title":"Front Immunol"},{"key":"4596_CR268","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lor\u00e9 K, Pardi N (2022) Innate immune mechanisms of mRNA vaccines. Immunity 55:1993\u20132005. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.014","journal-title":"Immunity"},{"key":"4596_CR269","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.virol.2015.12.014","volume":"489","author":"M Veselinovic","year":"2016","unstructured":"Veselinovic M, Yang K-H, Sykes C, Remling-Mulder L, Kashuba ADM, Akkina R (2016) Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: implications for HIV pre-exposure prophylaxis. Virology 489:173\u2013178. https:\/\/doi.org\/10.1016\/j.virol.2015.12.014","journal-title":"Virology"},{"key":"4596_CR270","doi-asserted-by":"publisher","first-page":"9884","DOI":"10.1038\/s41467-024-54289-9","volume":"15","author":"A Vijayan","year":"2024","unstructured":"Vijayan A, Vogels R, Groppo R, Jin Y, Khan S, Van Kampen M et al (2024) A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and na\u00efve non-human primates. Nat Commun 15:9884. https:\/\/doi.org\/10.1038\/s41467-024-54289-9","journal-title":"Nat Commun"},{"issue":"4","key":"4596_CR271","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041053","volume":"15","author":"A Vogelaar","year":"2023","unstructured":"Vogelaar A, Marcotte S, Cheng J, Oluoch B, Zaro J (2023) Use of microfluidics to prepare lipid-based nanocarriers. Pharmaceutics 15(4):1053. https:\/\/doi.org\/10.3390\/pharmaceutics15041053","journal-title":"Pharmaceutics"},{"issue":"1","key":"4596_CR272","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00549-y","volume":"7","author":"EA Voigt","year":"2022","unstructured":"Voigt EA, Gerhardt A, Hanson D, Jennewein MF, Battisti P, Reed S, Singh J, Mohamath R, Bakken J, Beaver S, Press C, Soon-Shiong P, Paddon CJ, Fox CB, Casper C (2022) A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability. NPJ Vaccines 7(1):136. https:\/\/doi.org\/10.1038\/s41541-022-00549-y","journal-title":"NPJ Vaccines"},{"issue":"2","key":"4596_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2025.102547","volume":"36","author":"MN Vu","year":"2025","unstructured":"Vu MN, Pilapitiya D, Kelly A, Koutsakos M, Kent SJ, Juno JA, Tan H-X, Wheatley AK (2025) Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines. Mol Ther Nucleic Acids 36(2):102547. https:\/\/doi.org\/10.1016\/j.omtn.2025.102547","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"4596_CR274","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00262-019-02442-5","volume":"69","author":"NA Wages","year":"2020","unstructured":"Wages NA, Slingluff CL, Bullock TN, Petroni GR (2020) Tailoring early-phase clinical trial design to address multiple research objectives. Cancer Immunol Immunother 69(1):95\u2013102. https:\/\/doi.org\/10.1007\/s00262-019-02442-5","journal-title":"Cancer Immunol Immunother"},{"key":"4596_CR275","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01775-23","volume":"15","author":"J Wan","year":"2024","unstructured":"Wan J, Wang Z, Wang L, Wu L, Zhang C, Zhou M et al (2024) Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses. Mbio 15:e01775-23. https:\/\/doi.org\/10.1128\/mbio.01775-23","journal-title":"Mbio"},{"key":"4596_CR276","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Viant C, Gaebler C et al (2021) Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med 13:eabf1555. https:\/\/doi.org\/10.1126\/scitranslmed.abf1555","journal-title":"Sci Transl Med"},{"issue":"1","key":"4596_CR277","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00766-z","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Wang Y, Yuan C, Xu X, Zhou W, Huang Y, Lu H, Zheng Y, Luo G, Shang J, Sui M (2023a) Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats. NPJ Vaccines 8(1):169. https:\/\/doi.org\/10.1038\/s41541-023-00766-z","journal-title":"NPJ Vaccines"},{"key":"4596_CR278","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102045","volume":"34","author":"Z Wang","year":"2023","unstructured":"Wang Z, Jacobus EJ, Stirling DC, Krumm S, Flight KE, Cunliffe RF, Mottl J, Singh C, Mosscrop LG, Santiago LA, Vogel AB, Kariko K, Sahin U, Erbar S, Tregoning JS (2023b) Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice. Mol Ther Nucleic Acids 34:102045. https:\/\/doi.org\/10.1016\/j.omtn.2023.102045","journal-title":"Mol Ther Nucleic Acids"},{"key":"4596_CR279","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/vaccines12101148","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang J, Ding Y, Chong K, Cui M, Cao Z, Tang C et al (2024) Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery. Vaccines 12:1148. https:\/\/doi.org\/10.3390\/vaccines12101148","journal-title":"Vaccines"},{"key":"4596_CR280","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/vaccines13050537","volume":"13","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li L, Liang M, Liu G, Lu Y (2025) Impact of B18R-encoding messenger ribonucleic acid co-delivery on neutralizing antibody production in self-amplifying messenger ribonucleic acid vaccines. Vaccines 13:537. https:\/\/doi.org\/10.3390\/vaccines13050537","journal-title":"Vaccines"},{"key":"4596_CR281","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e328360eac6","volume":"27","author":"JD Watkins","year":"2013","unstructured":"Watkins JD, Sholukh AM, Mukhtar MM, Siddappa NB, Lakhashe SK, Kim M et al (2013) Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission. AIDS 27:F13-20. https:\/\/doi.org\/10.1097\/QAD.0b013e328360eac6","journal-title":"AIDS"},{"key":"4596_CR282","doi-asserted-by":"publisher","DOI":"10.3390\/polym10030267","volume":"10","author":"T Ways","year":"2018","unstructured":"Ways T, Lau W, Khutoryanskiy V (2018) Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers 10:267. https:\/\/doi.org\/10.3390\/polym10030267","journal-title":"Polymers"},{"key":"4596_CR283","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","volume":"375","author":"P-S Wei","year":"2024","unstructured":"Wei P-S, Thota N, John G, Chang E, Lee S, Wang Y, Ma Z, Tsai Y-H, Mei K-C (2024) Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies. J Control Release 375:366\u2013388. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.030","journal-title":"J Control Release"},{"issue":"1","key":"4596_CR284","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft RA, Kowalski PS, Anderson DG (2018) Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun 9(1):2629. https:\/\/doi.org\/10.1038\/s41467-018-05096-6","journal-title":"Nat Commun"},{"key":"4596_CR285","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trsl.2021.11.009","volume":"242","author":"J Whitley","year":"2022","unstructured":"Whitley J, Zwolinski C, Denis C, Maughan M, Hayles L, Clarke D, Snare M, Liao H, Chiou S, Marmura T, Zoeller H, Hudson B, Peart J, Johnson M, Karlsson A, Wang Y, Nagle C, Harris C, Tonkin D, Fraser S, Capiz L, Zeno CL, Meli Y, Martik D, Ozaki DA, Caparoni A, Dickens JE, Weissman D, Saunders KO, Haynes BF, Sempowski GD, Denny TN, Johnson MR (2022) Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials. Transl Res 242:38\u201355. https:\/\/doi.org\/10.1016\/j.trsl.2021.11.009","journal-title":"Transl Res"},{"key":"4596_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103225","volume":"24","author":"TR Wiche Salinas","year":"2021","unstructured":"Wiche Salinas TR, Gosselin A, Raymond Marchand L, Moreira Gabriel E, Tastet O, Goulet J-P et al (2021) IL-17A reprograms intestinal epithelial cells to facilitate HIV-1 replication and outgrowth in CD4+ T cells. iScience 24:103225. https:\/\/doi.org\/10.1016\/j.isci.2021.103225","journal-title":"iScience"},{"key":"4596_CR287","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3389\/fimmu.2018.01860","volume":"9","author":"MM Wilk","year":"2018","unstructured":"Wilk MM, Mills KHG (2018) CD4 TRM cells following infection and immunization: implications for more effective vaccine design. Front Immunol 9:1860. https:\/\/doi.org\/10.3389\/fimmu.2018.01860","journal-title":"Front Immunol"},{"key":"4596_CR288","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coi.2020.05.001","volume":"65","author":"F Wimmers","year":"2020","unstructured":"Wimmers F, Pulendran B (2020) Emerging technologies for systems vaccinology \u2014 multi-omics integration and single-cell (epi)genomic profiling. Curr Opin Immunol 65:57\u201364. https:\/\/doi.org\/10.1016\/j.coi.2020.05.001","journal-title":"Curr Opin Immunol"},{"key":"4596_CR289","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249499","volume":"16","author":"AV Wisnewski","year":"2021","unstructured":"Wisnewski AV, Campillo Luna J, Redlich CA, Ansari AA, editor (2021) Human IgG and IgA responses to COVID-19 mRNA vaccines. PLoS ONE 16:e0249499. https:\/\/doi.org\/10.1371\/journal.pone.0249499","journal-title":"PLoS ONE"},{"key":"4596_CR290","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/1061186X.2020.1726356","volume":"28","author":"CY Wong","year":"2020","unstructured":"Wong CY, Al-Salami H, Dass CR (2020) Cellular assays and applied technologies for characterisation of orally administered protein nanoparticles: a systematic review. J Drug Target 28:585\u2013599. https:\/\/doi.org\/10.1080\/1061186X.2020.1726356","journal-title":"J Drug Target"},{"key":"4596_CR291","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/vaccines12020186","volume":"12","author":"L Wu","year":"2024","unstructured":"Wu L, Li X, Qian X, Wang S, Liu J, Yan J (2024) Lipid nanoparticle (LNP) delivery carrier-assisted targeted controlled release mRNA vaccines in tumor immunity. Vaccines 12:186. https:\/\/doi.org\/10.3390\/vaccines12020186","journal-title":"Vaccines"},{"issue":"9","key":"4596_CR292","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","volume":"9","author":"Q Xu","year":"2015","unstructured":"Xu Q, Ensign LM, Boylan NJ, Sch\u00f6n A, Gong X, Yang J-C, Lamb NW, Cai S, Yu T, Freire E, Hanes J (2015) Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo. ACS Nano 9(9):9217\u20139227. https:\/\/doi.org\/10.1021\/acsnano.5b03876","journal-title":"ACS Nano"},{"key":"4596_CR02","doi-asserted-by":"publisher","unstructured":"Xu K, Gao B, Li J, Xiang Y, Cao L, Zhao M (2023) Clinical features, diagnosis, and \u200emanagement of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease. Human Vaccines \u200eImmunotherapeutics 19(2):2220630. https:\/\/doi.org\/10.1080\/21645515.2023.2220630","DOI":"10.1080\/21645515.2023.2220630"},{"issue":"1","key":"4596_CR293","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03438-3","volume":"23","author":"L Xu","year":"2025","unstructured":"Xu L, Zhang J, Luo J, Cui Y, Chen J, Zeng B, Deng Z, Shao L (2025) Double-sided protector\" janus hydrogels for skin and mucosal wound repair: applications, mechanisms, and prospects. J Nanobiotechnology 23(1):387. https:\/\/doi.org\/10.1186\/s12951-025-03438-3","journal-title":"J Nanobiotechnology"},{"key":"4596_CR294","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.07.036","author":"P Yousefpour","year":"2025","unstructured":"Yousefpour P, Ghosh AR, Chawla H, Yeung R, Gregory J, Si K et al (2025) Augmented humoral responses to HIV Env trimers delivered as transmembrane immunogens by self-replicating RNA. Mol Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.036","journal-title":"Mol Ther"},{"key":"4596_CR295","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.02.055","volume":"381","author":"H Zhang","year":"2025","unstructured":"Zhang H, Barz M (2025) Investigating the stability of RNA-lipid nanoparticles in biological fluids: unveiling its crucial role for understanding LNP performance. J Control Release 381:113559. https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.055","journal-title":"J Control Release"},{"issue":"12","key":"4596_CR296","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1038\/s41591-021-01574-5","volume":"27","author":"P Zhang","year":"2021","unstructured":"Zhang P, Narayanan E, Liu Q, Tsybovsky Y, Boswell K, Ding S, Hu Z, Follmann D, Lin Y, Miao H, Schmeisser H, Rogers D, Falcone S, Elbashir SM, Presnyak V, Bahl K, Prabhakaran M, Chen X, Sarfo EK, Ambrozak DR, Gautam R, Martin MA, Swerczek J, Herbert R, Weiss D, Misamore J, Ciaramella G, Himansu S, Stewart-Jones G, McDermott A, Koup RA, Mascola JR, Finzi A, Carfi A, Fauci AS, Lusso P (2021) A multiclade env\u2013gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques. Nat Med 27(12):2234\u20132245. https:\/\/doi.org\/10.1038\/s41591-021-01574-5","journal-title":"Nat Med"},{"issue":"5","key":"4596_CR297","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/jbm.a.37356","volume":"110","author":"H Zhang","year":"2022","unstructured":"Zhang H, Han X, Alameh M, Shepherd SJ, Padilla MS, Xue L, Butowska K, Weissman D, Mitchell MJ (2022) Rational design of anti\u2010inflammatory lipid nanoparticles for mRNA delivery. J Biomed Mater Res A 110(5):1101\u20131108. https:\/\/doi.org\/10.1002\/jbm.a.37356","journal-title":"J Biomed Mater Res A"},{"key":"4596_CR298","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/vaccines11101580","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang W, Pfeifle A, Lansdell C, Frahm G, Cecillon J, Tamming L et al (2023a) The expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice. Vaccines 11:1580. https:\/\/doi.org\/10.3390\/vaccines11101580","journal-title":"Vaccines"},{"key":"4596_CR01","doi-asserted-by":"publisher","unstructured":"Zhang HQ, Cao BZ, Cao QT, Hun M, Cao L, Zhao MY (2023b) An analysis of \u200ereported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination. \u200eHuman Vaccines immunotherapeutics 19(2):2263229. \u200ehttps:\/\/doi.org\/10.1080\/21645515.2023.2263229","DOI":"10.1080\/21645515.2023.2263229"},{"key":"4596_CR299","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2147\/JIR.S499403","volume":"18","author":"S Zhang","year":"2025","unstructured":"Zhang S, Chen W, Zhou J, Liang Q, Zhang Y, Su M, Zhang Z, Qu J (2025) The benefits and safety of monoclonal antibodies: implications for cancer immunotherapy. J Inflamm Res 18:4335\u20134357. https:\/\/doi.org\/10.2147\/JIR.S499403","journal-title":"J Inflamm Res"},{"issue":"4","key":"4596_CR300","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1021\/acs.bioconjchem.5c00037","volume":"36","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Cheng H, Jiang S, Tai W (2025) Fc multisite conjugation and prolonged delivery of the folate-targeted drug conjugate EC140. Bioconjug Chem 36(4):762\u2013769. https:\/\/doi.org\/10.1021\/acs.bioconjchem.5c00037","journal-title":"Bioconjug Chem"},{"issue":"6","key":"4596_CR301","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jcmgh.2016.09.003","volume":"2","author":"A Ziegler","year":"2016","unstructured":"Ziegler A, Gonzalez L, Blikslager A (2016) Large animal models: the key to translational discovery in digestive disease research. Cell Mol Gastroenterol Hepatol 2(6):716\u2013724. https:\/\/doi.org\/10.1016\/j.jcmgh.2016.09.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4596_CR302","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/v2020413","volume":"2","author":"G Zimmer","year":"2010","unstructured":"Zimmer G (2010) RNA replicons\u2014a new approach for influenza virus immunoprophylaxis. Viruses 2:413\u2013434. https:\/\/doi.org\/10.3390\/v2020413","journal-title":"Viruses"},{"key":"4596_CR303","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1016\/j.vaccine.2018.04.066","volume":"36","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann P, Curtis N (2018) The influence of the intestinal microbiome on vaccine responses. Vaccine 36:4433\u20134439. https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.066","journal-title":"Vaccine"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04596-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04596-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04596-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:08:04Z","timestamp":1779797284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04596-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":303,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4596"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04596-6","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This article is a review and does not involve studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consent to the publication of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"68"}}